With over 13 years of experience in the global eyecare and eyewear industry, Andrea Fornari has held executive roles spanning corporate offices in Milan, Dubai, and South Africa. Currently, he leads the GCC and Export markets in EssilorLuxottica, focusing on frames, lenses, instruments, apparel, and wearable solutions. His strategic vision and leadership drive growth and cross-regional business development, making significant contributions to the industry. Andrea is known for his ability to foster innovation and build strong partnerships across diverse markets, positioning him as a key player in shaping the future of eyewear and eyecare.
Professor and consultant of Cornea and Uveitis services at Department of Ophthalmology KAUH, College of Medicine, King Saud University, Riyadh, Saudi Arabia
MBBS (KSA), DES-OPH (PARIS), DISSO (SWISS), FEBO (PARIS). Current Appointments:
Associate professor and Consultant, Retina and Uveitis Division, Department of Ophthalmology, King Saud University, Riyadh, Saudi Arabia
Dr. Adnan Alawami is a Canadian and American board-certified vitreoretinal surgeon, currently practicing at Dhahran Eye Specialist Hospital. He earned his medical degree with first-class honors from Imam Abdulrahman Bin Faisal University in 2017, then completed his ophthalmology residency at the University of Ottawa in 2023. He went on to finish a high-intensity fellowship in medical and surgical retina at the same institution, graduating in 2025. Dr. Alawami is dedicated to providing expert care in complex retinal conditions using the latest surgical techniques.
Current Position: Sept 2007 up to date Zayed Military Hospital (ZMH) Cornea and Anterior Segment Consultant • Established Cornea Service • Established Corneal Transplantation Program • Refractive Surgery including Femtosecond Laser, complicated and advanced refractive procedures • Intrastroaml Corneal Rings • Lamellar and Full thickness Corneal Transplants (PKP, DALK, DSAEK, DMEK) • Limbal Stem Cells Transplants • Amniotic Membranes Surgeries • Phaco/ECCE, Triple Procedure • Toric Intraocular Contact lens Surgery • Premium IOL (multifocal, Toric) • Iris and Scleral Fixated IOL • Emergency Ocular Surgeries. • Pediatrics cornea and cataracts Dec 2012 up to date Shaikh Khalifa Medical City • Consultant Cornea and anterior segment Surgeon Prizes and Awards: • Al Nukhba Award by Abu Dhabi Tourism Authority, Government of Abu Dhabi, 2017: An award for successful leading events in the Capital, Granted for Abu Dhabi Ophthalmology Review Conference, ADORE as a founder and President. • ACGME-I accreditation for Ophthalmology Award, SEHA Feb, 2017 • Exemplary Physician in the Medical Services Corps, 2014: This prize is a warded to one physician yearly for an outstanding performance at clinical and administrative roles. • Scholarship from Zayed University for the EHCMA course, 2010 • Sheikh Rashid’s Award for Scientific Achievement, 2006: Awarded to exceptional UAE nationals who obtain Board degrees. • First Prize Clinician, McGill Ophthalmology Clinical and Research Day, 2004: This Prize is given by the department of Ophthalmology, McGill University to the best clinical research. • Sheikh Rashid’s Award for Scientific Achievement, 1999: This is a national award that is given to a graduate who is nominated by the Medical School for the best performance throughout the 7 years of medical school • Excellence in Final Integrated Exam (FIE) Award, 1999: The FIE is an integrated exit examination from medical school and it consists of: Oral, Practical, Clinical and written parts. The exam is done with the participation of external examiners from the UK, Canada and USA. This award is given to one student per class. • Excellence in Clinical Sciences Course II, 1999: This award is given to one student per year who has the best performance throughout the second year of Clinical Sciences Course. • Excellence in Clinical Sciences Course I, 1998: This award is given to one student per year who has the best performance throughout the first year of Clinical Sciences
Dr. Ahmed AlMarzouqi is a double-certified Ophthalmologist renowned for his expertise in retinal surgery and diabetic retinopathy. He graduated from the United Arab University in 2010 with a bachelor's degree in Medicine and Surgery before travelling to Munich, Germany, to complete his ophthalmology residency at the Eye Clinic of Ludwig Maximilian University.
Dr. AlMarzouqi further distinguished himself by obtaining his German specialist degree (Facharzt) and the FEBO (European Board in Ophthalmology) certification in 2017/2018, solidifying his status as a double-certified practitioner. He then joined the Eye Clinic at the Technical University of Munich, where he completed a fellowship in vitreoretinal surgeries and served as a senior specialist, managing a wide range of complex medical and surgical retinal cases.
In 2020, Dr. AlMarzouqi returned to the UAE to join the retinal team at Tawam Hospital in Al Ain as a consultant ophthalmologist. He was then promoted as head of department, managing the ophthalmology division in both Tawam Hospital and Sheikh Tahnoon Medical City, Al Ain.
In 2025, Dr. AlMarzouqi joined Burjeel Royal Hospital, Al Ain as head of department of ophalmology of Burjeel Holdings (Al Ain Region) and consultant ophthalmologist. In addition to his role at Burjeel Hospital, he is actively engaged in practice at the North American Lasik and Eye Surgery Centre, Dubai.
An influential figure in the field, Dr AlMarzouqi actively contributes to ophthalmology in the UAE and internationally. He frequently speaks at prestigious local and global conferences and is affliated with several respected professional organizations, including the German Ophthalmology Society and European Board of Ophthalmology.
Dr, Alneyadi is a consultant ophthalmologist, having earned his medical degree from the Royal College of Surgeons in Ireland. He received the German Board of Ophthalmology (Facharzt) and the European Board of Ophthalmology (Paris, France). He has 5 in Cataract and Refractive Surgery
Ahmed H. Assaf is a professor of Ophthalmology in the faculty of medicine, Ain Shams University, a fellow of the royal college of surgeons of Edinburgh and a consultant of phacorefractive surgery in Al-Watany eye hospital in Cairo. Cataract surgery with premium IOLs is his primary focus, together with the implementation of Femtosecond laser technology, which consists of about 30% of his total annual volume of cataract surgery. He awarded the best paper of session about his study of femtosecond laser cataract surgery in different nuclear density during ASCRS 2017. He started to implant presbyopia-correcting IOLs since 2002 and has substantial experience in various designs of multifocal, new trifocal, and extended depth of focus IOLs. He participated in the pre-launch visual outcome study of AcrySof IQ ReSTOR multifocal toric IOL and presented his results during ESCRS annual meeting in Paris, 2010. He has a particular interest in complicated cataract surgery with intra-scleral haptic fixation (ISHF), together with iris repair and different techniques of pupilloplasty. Work History:
Dr. Ahmed Awadein, MD, FRCS is a Professor of Ophthalmology at Cairo University.
He received his doctorate degree from Cairo University in 2003 and his ophthalmology fellowship degree from the Royal College of Physicians and Surgeons of Glasgow in 2004. He acquired clinical fellowship training in Johns Hopkins Hospital in Maryland, USA in 2006, where he received an intensive medical and surgical hands-on training in the field of pediatric ophthalmology and strabismus.
Dr. Ahmed Awadein is specialized in pediatric ophthalmology and strabismus and has performed over 15000 strabismus operations to date, including complex and recurrent cases. He has over 70 international publications and chapter books in the field of pediatric ophthalmology and strabismus and has developed a computerized test to assist in the evaluation of patients with diplopia. He also participated as an instructor in various national and international conferences and is currently the secretary general of the Egyptian Association for Pediatric Ophthalmology and Strabismus (EAPOS), as well as a board member of the Egyptian Ophthalmological Society, the Egyptian Society for Ophthalmic Investigations, and the Egyptian Council for Ophthalmology Fellowship. Dr Awadein is also the editor-in-chief of the Journal of the Egyptian Ophthalmological Society.
Dr.Ahmed El Khashab is the Head of Vitreoretinal Unit ,Co-founder and the Medical Director of Eye Consultants Center since June 2013.He previously filled the position of Head of Vitreoretinal department in Magrabi Eye Hospitals in Al Madinah (KSA), Abu Dhabi and Dubai (UAE) from 2005 -2012.He then moved on to fill the position of Head of the Vitreoretinal unit and Diabetic Eye Center in Al Sharif Eye Center in Dubai.
Furthermore, Dr. El Khashab is a co-founder of the Gulf Retina Group and is the Head of its Scientific Committee. He’s also the treasurer of the ESO Retina and Uveitis club.
He’s been the regional representative in the American Society of Retina Specialists since 2015.Dr. El Khashab has been a reviewer of the Middle East Edition of the British Journal of Ophthalmology since 2014.
Dr. El Khashab did thousands of successful vitreoretinal and anterior segment procedures for all different indications from diabetic retinopathy ,retinal detachment ,macular surgeries ,retinopathy of prematurity ,trauma and phacoemulsification during his over 20 years of Experience .
Dr.Ahmed El Khashab received his Medical degree with honors from Ain Shams University Cairo, Egypt in 1995. He then, completed a three year Ophthalmology Residency program and received his Masters degree in Ophthalmology ( excellent ) from Ain Sham University. Following this, he started his specialized Vitreoretinal surgical training in El Noor Eye Hospital in Egypt and Magrabi Eye Hospital in KSA then completed the European Vitreoretinal Training program in Germany.
He received his Diploma of Fellowship in Ophthalmology from the Royal College of Physicians and Surgeons of Glasgow in 2003.He also in that year became a certified member of the International Council of Ophthalmology of Cambridge.
-MD, FRCS -Vitreoretinal Consultant, SKMC, UAE -Assistant Professor of Ophthalmology, Benha university ,Egypt -Clinical adjunct Professor of Ophthalmology, Khalifa university, UAE
Ahmed Elmassry MD,PhD
Ahmed Mostafa Abdelrahman, MD, FRCSED. A professor of Ophthalmology, Cairo University, since 2009 till present. In 2015, he achieved the Professional Postgraduate Diploma in Total Quality Management (TQM) for Healthcare Reform. He is the founder and president of the Egyptian Society for Continuous Ophthalmic Education, (EGSCOE on telegram & Website: egscoe.info). He is a glaucoma consultant with national and international publications and innovations in the field of glaucoma surgery. He is a glaucoma reviewer for a number of PubMed prestigious Ophthalmology. He is the owner of the Giza specialized Eye center (http://www.gizaeyecenter.com) with the Glaucoma Management and Education center being part of it. 2016, the Royal College of Edinburgh council appointed him to be an examiner in the college exams. He received the Education Award from the American Academy of Ophthalmology in 2019.
Dr. Alaa AlAli; MD, MHPE, FRCSC, DABO
Dr. Alaa obtained her medical school degree from National University of Ireland- Cork. She then continued her postgraduate training in Ophthalmology in Canada.
Dr. Alaa completed her residency in Ohthalmology at University of Toronto where she became a fellow of the Royal College of Surgeons- Canada.
She then completed a 1 year fellowship in pediatric ophthalmology and strabismus at Hospital for Sick Children- University of Toronto followed by a 2 years fellowship in vitreoretinal surgery at University of Toronto- Canada.
In addition, Dr. Alaa obtained her Master of Health Professions Education- Maastricht University/ Center for Education Research, and Innovation, Schulich School of Medicine University of Western Ontario- Canada.
Currently, Dr. Alaa is a Consultant Vitreoretinal Surgeon and Pediatric Ophthalmologist in Kuwait. She also hold the position as the Residency Program Director- Kuwait Board of Ophthalmology (KIMS)- Kuwait
Chairman and Managing Director-Dr.Agarwal’s group of eye hospitals and Eye Research Centre, 222, TTK Road, Alwarpet, Chennai 600018, Tamilnadu, India Past President- International Society of Refractive Surgery (ISRS) Secretary General- Indian Intraocular implant and Refractive Society (IIRSI) Amar Agarwal is the pioneer of Phakonit, which is Phako with a Needle Incision Technology. This technique became popularized as Bimanual phaco, Microincision cataract surgery (MICS) or Microphaco. He was the first to remove cataracts through a 0.7 mm tip with the technique called Microphakonit. He has also discovered No anaesthesia cataract surgery and FAVIT, a new technique to remove dropped nuclei. The air pump, which was a simple idea of using an aquarium fish pump to increase the fluid into the eye in bimanual phaco and co-axial phaco has helped prevent surge. This built the basis of various techniques of forced infusion for small incision cataract surgery. He has also discovered a new refractive error called Aberropia. He has also been the first to do a combined surgery of microphakonit (700 micron cataract surgery) with a 25 gauge vitrectomy in the same patient thus having the smallest incisions possible for cataract and vitrectomy. He is also the first surgeon to implant a new mirror telescopic IOL (LMI) for patients suffering from age-related macular degeneration. He has also been the first in the world to implant a Glued IOL. He also has brought out the technique of IOL Scaffold in which a three-piece IOL is injected into an eye between the iris and the nucleus to prevent the nucleus from falling down in posterior capsular ruptures. Hypersonic vitrectomy for cases of PC rupture was first done by him and he was the principal investigator for the first hypersonic vitrectomy cases done in the world. Pre Descemet’s Endothelial Keratoplasty or PDEK was started by Prof Agarwal. Dr Agarwal has designed a new instrument called the Trocar anterior chamber maintainer in complicated cases, which helps give infusion through the anterior chamber and works like a trocar cannula. He has also started a new technique of iris suturing called Single pass Four Throw (SFT) pupilloplasty. Subsequenly he started Pinhole pupilloplasty to treat patients with high astigmatism and higher order aberrations. Dr. Agarwal has performed more than 200 live surgeries at various conferences. His videos have won many awards at the film festivals of ASCRS, AAO and ESCRS. He has more than 250 peer review articles in top journals and has also written more than 80 books in Ophthalmology which have been published in English, Spanish, portugese and chinese. He is the Chairman and managing director of Dr.Agarwals group of eye hospitals with 221 eye hospitals in 11 countries.
Dr. Ammar Safar is American Board Certified in Ophthalmology and is a highly experienced consultant in vitreoretinal diseases and surgery. Dr. Ammar is the Medical Director of Moorfields Eye Hospitals in the UAE. He is based in Moorfields Eye Hospital Dubai.
Dr. Ammar undertook his medical training in Syria before moving to the United States for post-graduate training. He specialised in Ophthalmology at Georgetown University in Washington, DC. He then acquired an additional 2-year fellowship training in Vitreoretinal Diseases & Surgery at the University of Texas, Southwestern Medical Center in Dallas, Texas, USA. Dr. Ammar then went on to hold the position of Assistant and later Associate Professor and Director of Vitreoretinal Surgery at the Department of Ophthalmology, Jones Eye Institute, University of Arkansas for Medical Sciences, in the United States. In addition to his work in private practice, Dr. Ammar has undertaken research and clinical trials in areas such as diabetic retinopathy and age-related eye diseases, and published and presented extensively.
Assistant Professor of Ophthalmology at King Abdulaziz University, Saudi Arabia, and a Vitreoretinal Consultant. Affiliation Jeddah Eye Hospital and Magrabi Health – Morjan Center. He specializes in medical and surgical retina, complex vitreoretinal procedures, and uveitis management. completed advanced fellowship training in Lyon, France, including a second-year fellowship in Uveitis and Vitreoretinal Surgery—encompassing endoscopic vitreoretinal techniques—at Croix-Rousse University Hospital. He previously completed his first- vitreoretinal fellowship at the renowned Édouard Herriot University Hospital. He holds the French Board of Ophthalmology (DES) from Claude Bernard University Lyon (and the European Board of Ophthalmology (EBO). He also served as a Consultant in Vitreoretinal Surgery at Croix-Rousse University Hospital, Lyon, France
Andrew G. Lee is the Herb and Jean Lyman Centennial Chair in Ophthalmology and is the Founding Chairman of the Blanton Eye Institute, Department of Ophthalmology at Houston Methodist Hospital in Houston, Texas. He is Professor of Ophthalmology, Neurology, and Neurosurgery at Weill Cornell Medicine and an adjunct professor of Ophthalmology at Baylor College of Medicine; Texas A and M College of Medicine; University of Iowa and the University of Buffalo; and Clinical Professor at the University of Texas Medical Branch (UTMB) in Galveston, Texas and the UT MD Anderson Cancer Center.
He is a graduate of the University of Virginia (UVA) undergraduate and UVA School of Medicine. He was an ophthalmology resident and chief resident at Baylor College of Medicine and a clinical neuro-ophthalmology fellow and Fight for Sight postdoctoral research fellow at the Wilmer Eye Institute, the Johns Hopkins Hospital.
Dr. Lee has served in numerous leadership roles at the American Academy of Ophthalmology (AAO) and has received the AAO Achievement Award, Senior Achievement Award, Secretariat Award (three times), and Lifetime Achievement Award. He is a past President, a past Chairman of the Board, and Senior VP for Advocacy of the North American Neuro-ophthalmology Society.
Dr. Lee has received the teaching award 15 times at 7 different academic institutions including the Osler Excellence in Teaching Award, the Baylor College of Medicine Dan B. Jones Teaching Award, University of Iowa Charles Phelps Award, the Texas A and M Mid Career Education award, the HMH Presidential Excellence in Education, and the Houston Methodist Hospital Sherilynn Gordon Memorial Leadership Award.
Dr. Lee has been the invited speaker at over 400 national and international medical meetings; has written over 600 peer-reviewed publications and 14 full textbooks; and has given 15 named lectures. His h-index is 68 and his i-10 is 367 with over 18,000 citations. He has been named one of top 30 ophthalmologists in the United States by Newsweek magazine and is the only neuro-ophthalmologist on the list.
He lives in Houston, Texas with his wife, Hilary; his two daughters (Rachael and Virginia), and his two cats (Lola and Miss Kitty).
Dr. Andrew H. Malem, MB BChir, MA, Cantab, FRCOphth, is a Staff Physician specializing in Pediatric Ophthalmology and Strabismus at the Eye Institute, Cleveland Clinic Abu Dhabi.
Dr. Malem studied medicine at the University of Cambridge (Gonville & Caius College), during which time he was awarded a Studentship to undertake research into oculomotor neurophysiology with the late Professor Carpenter.
Dr. Malem subsequently undertook all of his core ophthalmology training in Wessex, UK, where he was involved in teaching and training ophthalmology residents. He was awarded his Certificate of Completion of Training (CCT), following which he undertook further subspecialist Fellowship training.
Dr. Malem is one of the few people who has completed two separate subspecialist Fellowships in Pediatric Ophthalmology and Strabismus. The first was completed at Addenbrooke’s Hospital, Cambridge, UK, where he also taught Neurobiology and Human behaviour to undergraduate medical students as a College Supervisor at the University of Cambridge.
On completion of his Cambridge Fellowship, Dr. Malem continued working at Addenbrooke’s Hospital as a Locum Consultant before undertaking a second Fellowship at the world famous Hospital for Sick Children (SickKids) in Toronto, Canada. During his time in Toronto, Dr Malem trained in all aspects of Pediatric Ophthalmology and Strabismus and conducted further neuro-ophthalmic research, for which he was awarded a research grant from the Department of Visual Sciences. Dr. Malem continues to collaborate with his colleagues at SickKids on ongoing research projects.
Dr. Malem is a Fellow of the Royal College of Ophthal-mologists (FRCOphth). He was one of the youngest ophthalmologists to be elected to the Panel of Examiners of the Royal College of Ophthalmologists (RCOphth) and he examines UK and international ophthalmology candidates for the FRCOphth refraction and final Fellowship exams.
In 2022, Dr. Malem was awarded the inaugural David Laws Fellowship from the British Isles Pediatric Oph-thalmology and Strabismus Association (BIPOSA).
Dr. André Maia is a Brazilian ophthalmologist specializing in clinical and surgical retina. He earned his M.D. and completed his ophthalmology residency at the Federal University of São Paulo (UNIFESP), where he also obtained a Ph.D. in Medicine (Ophthalmology) in 2003, with a thesis on retinal vein catheterization for the treatment of venous occlusions. He pursued a Retina fellowship at McGill University in Canada, under the supervision of Drs. David Chow and Michael Kapusta. Dr. Maia is currently the medical director of Retina Clinic in São Paulo and leads a specialized team focused on the diagnosis and management of complex retinal diseases. He has been an active contributor to scientific research and education in ophthalmology and has presented at multiple national and international congresses. He is fluent in Portuguese and English, and has working knowledge of Spanish and French. His expertise bridges advanced surgical techniques and evidence-based clinical practice.
Vitreoretina and Uveitis Specialist
Arif O. Khan MD is Consultant in Pediatric Ophthalmology & Strabismus and in Ocular Genetics at Cleveland Clinic Abu Dhabi and is Professor of Ophthalmology at Cleveland Clinic Lerner College of Medicine. Previously, until the end of 2015, he was Senior Academic Consultant at the King Khaled Eye Specialist Hospital in Riyadh, Saudi Arabia, and Senior Scientist at the King Faisal Specialist Hospital & Research Center, also in Riyadh. Before he moved to the Gulf region in January 2002, Dr. Khan was in private practice in New York. Dr. Khan’s clinical and research interests are the management and genetics of ocular developmental disorders and strabismus. He is a frequent presenter at international ophthalmology meetings and has authored hundreds of scientific publications related to his field. Dr. Khan is Editor for the American Academy of Ophthalmology Basic and Clinical Science Course book on Pediatric Ophthalmology & Strabismus (BCSC Section 6) and Editorial Board member for journal Ophthalmic Genetics. Previously, he served as International Consultant for the American Academy of Ophthalmology curriculum in Pediatric Ophthalmology & Strabismus, Editorial Board member for the Journal of AAPOS, and Associate Editor for the Journal of AAPOS. Accolades: •Senior Achievement Award,American Academy of Ophthalmology 2021 •American Ophthalmological Society Election 2015 •Honor Award,American to Association for Pediatric Ophthalmology & Strabismus 2015 •International Scholar Award, American Academy of Ophthalmology 2012 •International Education Award, American Academy of Ophthalmology 2010 •Achievement Award , American Academy of Ophthalmology 2010 Certifications: •US National Board Medical Examination certification #425729 •American Board of Ophthalmology certification •Saudi Council for Health Specialties, Health Authority of Abu Dhabi
Dr. Aseel AlKandari; MD, KBOphth
Dr. Aseel obtained her medical school degree from Arabian Gulf University- Kingdom of Bahrain. She then continued her postgraduate training in Ophthalmology in Kuwait, where she joined Kuwait Board of Ophthalmology, served as the Chief Resident for 2 years, and graduated in 2024.
Currently, Dr. Aseel is working in the Vitreoretinal Surgery Unit in Kuwait and is also one of the Assistant Program Directors at Kuwait Board of Ophthalmology
Dr. Ashvin Agarwal is the Chief Clinical Officer at Dr. Agarwal's Eye Hospital, a premier eye care group spanning over 170+ locations globally. In this capacity, he spearheads initiatives vital to maintaining the organization's clinical excellence and fostering its expansion. Dr. Agarwal has been honored with the prestigious Golden Apple Award from ASCRS and esteemed Secretariat award from American Academy of Ophthalmology accolade, underscoring his profound contributions to the field. Additionally, his prolific scholarly output includes over 25 publications and the authorship of 10 seminal books, reflecting his dedication to advancing knowledge in ophthalmology.
Dr. Ashwaq Bin Amro is a board-certified ophthalmologist and a fellowship-trained consultant in pediatric ophthalmology, adult strabismus, and pediatric glaucoma. She is currently working in Burjeel Medical City.
Dr. Bader AlQahtani, MD (Hons.), FICO, FACS, FWCRS, is a Consultant Ophthalmologist specializing in Cornea, Cataract, and Refractive Surgery in Riyadh, Saudi Arabia. He is also the Vice-President of the Saudi Society of Cornea, Cataract and Refractive Surgery (SSCRS) and serves as an Adjunct Assistant Professor of Ophthalmology at Alfaisal University.
Dr. AlQahtani completed a prestigious advanced fellowship training in Cornea, Anterior Segment, and Refractive Surgery at the University of Ottawa, following which he earned fellowships from the American College of Surgeons (FACS) and the World College of Refractive Surgery (FWCRS). His scholarly work includes multiple peer-reviewed publications addressing keratoconus, corneal transplantation, refractive surgery outcomes, and anterior segment pathology.
He has been invited to present his research and surgical innovations at leading international meetings, including ESCRS, ASCRS, WKC, COS, and the Sally Letson Symposium. His clinical and academic interests focus on advanced keratoconus management, premium and complex cataract surgery, and corneal reconstruction techniques.
Dr Barbara Parolini was born in Verona, Italy, on April 17th, 1968.
She is an ophthalmic surgeon who exercises her practice, mainly in Italy, since 1997. She graduated in Italy from Medical School with laude in 1993 and obtained the diploma in Ophthalmology in 1997.
She has undertaken a postdoctoral fellowship at UCSF (San Francisco, USA) and at UMDNJ (Newark, USA), on retinal pigment epithelium transplantation in 1994-1995 and 1997-1998.
She has been Director of Clinical Studies for FDA for the Medjet Company, in Edison USA, in 1997-1998.
She works as consultant in foreign countries.
Her expertise are:
Approved at the exam of the Italian Ministry as University Associate Professor
Organiser of 3 international meetings, Retinitaly in 2015, 2016, 2017
Since 2016, VicePresident of the European VitreoRetina Society
Since 2020 Board member or Retina World Congress and leading the RWC- Global Research Group
She obtained a patent of a model of macular buckle and a kit for episcleral surgery.
Member of the following societies: GIVRE, SOI, AIMO, AAO, ASRS, EVRS
16 June 2023 Awarded with the DOC Retina Science Award
Professor Bruce Allan qualified in medicine from Cambridge in 1985, and was appointed as a Consultant Surgeon at Moorfields in 1998 after advanced specialist training in the UK, South Africa, and Australia. He was Training Director for the Corneal Service at Moorfields for over 10 years, and Service Director for Refractive Surgery from 2012 to 2019. He is currently chairing the Royal College of Ophthalmologists Refractive Surgery Standards Working Group and the European Society of Cataract and Refractive Surgeons (ESCRS) Digital Health Special Interest Group. He is an ESCRS Council and EU Cornea board member. He and his wife, Consultant Psychiatrist Dr Maria Teresa Casasus Borrell, live in North London with regular visits from their 3 daughters, Saskia, Sofia and Silvia. Outside work, He is a keen football fan and sailor. Professional activities include:
Burkhard Dick was born in a small town by the name of Brake in Northern Germany. After graduating from the local high school, he served for two years as a medical officer with Germany's NATO forces. He attended medical school at the University of Giessen, a city with a strong American presence during the Cold War, where he graduated in 1990, a year that saw German unification and changed Giessen's location where he began his residency in ophthalmology from bordertown at the edge of the Iron Curtain to suddenly being in the country's geographical centre.
Dick became head physician at the University Eye Hospital in 1995 before he moved to the Eye Hospital of the University of Mainz which bears the name of that city's greatest son, Johannes Gutenberg. Here he specialized in refractive and cataract surgery and became head of the hospital's Refractive Surgical Eye CareCenter in 1997. Shortly after becoming a clinical professor in Mainz, the University of Bochumoffered offered Burkhard Dick the position of head and director of its eye clinic and eye research centre which he accepted in 2006. Since then, the Bochum University Eye Clinic has become an internationally renowned institution with a constant output of highly ranked research papers and clinical studies, most of them published in the Journal of Cataract and Refractive Surgery and the Journal of Refractive Surgery.
Burkhard Dick became one of the first ophthalmic surgeons in Europe to use a femtosecond laser in cataract surgery; to date almost 12,000 eyes have been operated with that technology in Bochum.
For his pioneering work, he has been awarded a number of honours like the Choyce Medal of the British Ophthalmological Society, the Gold Medal Award of the Australian Society for Cataract and Refractive Surgery, the Waring Medal of the Journal of Refractive Surgery and, most recently, the Visionary Award of the American-European Congress of Ophthalmic Surgery (AECOS).
He currently serves as the Treasurer of the German Society of Cataract, Refractive and Interventional Surgery (DGII) after being President of the DGII for four years (2016-2020). He is a regular lecturer at international meetings like the AAO, DOG, DOC, DGII, ESCRS, APAO and ASCRS and has instructed fellows in the University Eye Hospital Bochum from 44 different countries in state-of-the-art cataract, refractive, glaucoma and vitreoretinal surgery.
Eye surgeon specializing inVitreoretinal Surgery, with over 35 years of experience. He currently works at the Miranza Group Institute of Ocular Microsurgery (IMO) in Barcelona and at Miranza Andorra. He is a founding member of the IMO and has worked at institutions such as the General Hospital Valle Hebrón and the General Hospital of Catalonia. He is an expert in pathologies such as high myopia, retinal detachment, severe ocular trauma, and diabetic retinopathy. He introduced innovative techniques such as Macular Translocation and Macular Buckling to Spain. He is an associate professor on the Master's Degree in Retina and Vitreous at the Autonomous University of Barcelona and a part-time lecturer on retina modules at the European School for Advanced Studies in Ophthalmology (ESASO).
Dr. McCabe serves as Chief Medical Officer at Eye Health America™. She is one of the foremost eye surgeons today, specializing in bladeless laser cataract surgery and LASIK at The Eye Associates in Sarasota, Florida. Dr. McCabe has performed over 45,000 cataract surgeries and more than 17,000 LASIK procedures. She has a keen interest in advancing the field of ophthalmology and has participated in numerous clinical trials, including innovations in intraocular lenses, perioperative medications, medications and devices to treat glaucoma, dry eye treatments and presbyopia correction.
Dr. McCabe continues to receive many prestigious and esteemed awards for her work in Ophthalmology, including being named a Castle Connolly Top Doctor – 2015, 2016, 2017, 2018, 2019 and 2020 for Ophthalmology. Castle Connolly also selected her for the first-ever Exceptional Women In Medicine Award for 2017, 2018, 2019 and in 2020. She was named to the OSN Premier Surgeon 300 List, and the Premier Surgeon 250 List of Leading Innovators in Premium IOL Cataract Surgery. She was also chosen a LASERVISION Top 100 LASIK Surgeon, elected President of CEDARS/ASPEN-2017, has received the American Academy Achievement Award, is the Vice President and incoming President of the Outpatient Ophthalmic Surgery Society, and serves on numerous editorial and subspecialty boards and committees. She is passionate about giving back to her local community, profession and globally and participates in charitable giving and volunteer efforts both at home and abroad. She is a board member of several charitable foundations in ophthalmology, including One World Global Health/Vision Quest, OOSS Gives, and others.
Dr. McCabe received her medical degree from the Medical College of Wisconsin and received her residency training at the prestigious Bascom Palmer Eye Institute at the University of Miami’s School of Medicine. She continues to share her expertise by publishing articles and book chapters as well as lecturing at national and international ophthalmological seminars.
Dr. Albreiki completed her residency training in ophthalmology at the Ottawa University in Canada. She then proceeded with a subspecialty in neuro-ophthalmology and adult strabismus surgery at the Ottawa Eye Institute. Dr. Albreiki worked as an assistant professor at the Eye Institute in Ottawa, Canada up until the summer of 2023. Dr. Albreiki has a passion for teaching, and was privileged to be the first to win the Dr. William Clarke medical teaching award two years in a row in 2015 and 2016 and a third time in 2023 and received the Golden Educator Honor from the National Guard Ophthalmology residency training program in Riyadh in 2025. When in Ottawa, Dr. Albreiki was a member of the EYE VAN, content expert and co-director for the ophthalmology undergraduate "Anglo stream" program, the founder of the "Mentor to inspire" mentorship program for the ophthalmology residents, an examiner for the national and international Royal College of Physicians and Surgeons of Canada, and the founder and organizer of the first and annual Canadian neuro-ophthalmology review course. Dr. Albreiki is currently working at King Fahad Medical City in Riyadh, Saudi Arabia and is Deputy program director for the Ophthalmology residency training program, is an external examiner for national and international ophthalmology residency board exams, and has been privileged to be a invited as a guest speaker nationally and internationally.
Heads the Cataract and Glaucoma departments at Megur Eye Care Centre, Bidar Karnataka India.
Specialises in Complex Cataract Surgeries. He is committed to teaching surgery through his personal Youtube Channel.
He has more than 200 presentations at various national and international meetings. He is a reviewer for the Indian Journal Of Ophthalmology. He has won many national & international awards for scientific Papers and Videos.
Dr. Dina Hossam Hassanein is a Professor of Ophthalmology at Cairo University and a Fellow of the Royal College of Physicians and Surgeons of Glasgow.
With over 15 years of clinical experience, she specializes in pediatric ophthalmology, strabismus, pediatric cataract surgery, and retinoblastoma.
Dr. Hassanein is a founding and board member of the Egyptian Association of Pediatric Ophthalmology and Strabismus. She also serves as the senior consultant for the ROP and Retinoblastoma services at Cairo University Children’s Hospital.
Born in Paris, in 1957 Medical studies in Paris. Residency (Ophthalmology) in Toulouse. Fellowship (PO&S) in Toulouse and Nantes (Pr Quere). Private practice in Toulouse and consultant surgeon in Toulouse Universitary Hospital from 1992, exclusively surgical pediatric ophthalmology and strabismology. Teacher in Toulouse Orthoptic school, and French Universitary Diploma of Strabology and Pediatric ophthalmology. Active member of French Society of Ophthalmology. Co-author of both Pediatric ophthalmology (2017) and Strabismology (2013) annual books of the society. Former vice president of French association of PO&S. (AFSOP) and of European Strabismological Association. Member of AAPOS, ISA, and WSPOS. Member of IPOSC for AFSOP representation. Local organiser of the last ESA/ISA meeting in my hometown, Toulouse in 2024. Field of works and publications since 1990: Deprivation amblyopia, Infantile cataracts, Infantile Strabismus, strabismus surgery in general, and more precisely in Infantile strabismus, Botulinum Toxin, in high Myopia, Oblique muscle surgery. Recent works on global scoring of IXT and surgery of exotropia with combined recess and resect on same muscle. … and still time for hobbies that I share with my 3 boys, 5 grand-children and my friends: music, mountain climbing, sailing, hiking.
Accomplished Senior Ophthalmologist with extensive experience in diagnosing and treating eye conditions, committed to enhancing patient vision through innovative techniques and comprehensive care. Skilled in performing complex anterior segment surgeries besides corneal graft and refractive surgeries.
With a journey filled with excellence, graduated from both primary and secondary (distinguished students’ school) with the top ranked student, to be followed by graduation from Baghdad College of Medicine with excellence, then certified as Senior Ophthalmologist in both Arab then Iraqi board of Ophthalmology with rank number 1.
Fabio Patelli, M.D. is the director of vitreoretinal service department of Ophthalmology at the ASST Santi Paolo e Carlo Hospital, University of Milan. He graduated magna cum laude at the University of Milan and specialized in Ophthalmology magna cum laude at the San Raffaele Hospital, University of Milan.
He did a brief fellowship in Boston at the Massachusetts Eye and Ear Infirmary Hospital with Prof Donald J D’Amico and in New York at the Columbia University with Prof. Stanley Chang.
His main field of interest since he was a resident is vitreoretinal surgery. He is author of many papers and Editor of THREE books about vitreoretinal surgery (Springer ed.).
Complementing his research endeavors, Dr. Patelli serves on numerous scientific advisory boards and addresses his research interests as an invited speaker at national and international conferences.
He is reviewer of several journal as “Retina”, “European Journal of Ophthalmology”, “Graefe’s Archive for clinical and experimental Ophthalmology” and he is part of the editorial board of “Journal of vitreoretinal diseases”.
He is one of the few surgeons worldwide who implanted the Argus II artificial retina in blind patients.
He is member of many ophthalmological societies such as SILO (Italian Society Laser in Ophthalmology), SOI (Italian Society of Ophthalmology), S.I.E.T.O. (Italian Society of Ocular Trauma), G.I.V.R.E. (Italian Group of vitreoretinal surgery), ASRS (American Society of Retina Specialists), EVRS (European Vitreo-Retinal Society), PAAO (Pan American Association of Ophthalmology), AAO (American Academy of Ophthalmology), Euretina (European retina society) Retina society.
Fahd Quhill is a Consultant Ophthalmologist specialising in Medical Retina and Ocular inflammatory disease at Moorfields Eye Hospital Dubai in Dubai Healthcare City. Dr. Fahd trained in Ophthalmology in the United Kingdom at Oxford, Birmingham and London, completing three Medical Retinal Fellowships in Birmingham, Wolverhampton and Moorfields Eye Hospital, London. He has undertaken research and served as principal investigator in numerous macular degeneration, retinal vein occlusion and diabetic macular oedema trials. He has published 27 research papers on retinal and ocular inflammatory disease in leading journal/s such as Ophthalmology, British Journal of Ophthalmology and Eye, among others.
Professor Farhad Hafezi is a refractive surgeon and ocular cell biologist. Combing patient care, research & development, and teaching, Hafezi is considered a pioneer and key opinion leader of corneal cross-linking (CXL). Hafezi is one of the most cited ophthalmologists of his generation. (> 260 peer-reviewed publications, h index of 63, > 17.000 citations, cumulative impact factor 1.045 points.
Born and raised in Rio de Janeiro, Brazil. After completing medical school and residency in Rio de Janeiro, Flavio went to McGill University, Montreal, Canada where he completed his Surgical Retina fellowship under mentorship of Drs Michael Kapusta and David Chow. Still at McGill, he also completed Ocular Oncology and Ophthalmic Pathology fellowships. Then finished his PhD degree in Science at University of São Paulo, Brazil.
He became an Associate Professor of the Department of Ophthalmology at Pontifícia Universidade Católica (PUC) – Rio de Janeiro and although he moved to Canada 15 years ago, still gives his annual Retina Course at PUC-Rio.
In Montreal, he serves as Full Professor from the Department of Ophthalmology, University of Montreal (UdeM), where he leads the clinical/surgical side of the translational research team at the Centre Universitaire d’Ophtalmologie, Maisonneuve-Rosemont Hospital (CUO-HMR), Montreal, Quebec, Canada. His main focus is on surgical management of complex vitreoretinal diseases, academic teaching, and surgical translational research up to clinical trials.
As a vitreoretinal surgeon, he has been developing and improving complex vitreoretinal surgical techniques to manage vitreoretinal diseases and now leads the CLOSE Study Group for large macular holes studies.
On the academic side, he was in charge of the Vitreoretinal Fellowship Program from the Retina Service, Department of Ophthalmology, UdeM for 5 years (2013-2018). He is now creating the Flavio Rezende Surgical Teaching Foundation (FIER) in memory of his recently departed father (a former well-known anterior segment surgeon in Brazil). He’s constantly involved in training fellows and residents at UdeM.
As a surgical translational researcher, he has developed surgical techniques to obtain vitreous biopsies in an ambulatory setting, providing instrumental material for the Neuro-Vascular Biology Research Unit at CUO-HMR. Two molecules out this lab are in ongoing clinical trials in the US and Canada.
Flavio was also involved for 5 years with the implantation of ARGUS 2 Retinal Chip implant and helped developing an innovative surgical technique for a new generation retinal chip.
And finally, in the past 4 years he has served as the Clinical Director at CUO-HMR and, as such, he has been committed to bringing further innovation to benefit his patients and the Quebec community. We have become now one of the first centers in Canada for subretinal gene therapy for previously untreatable retinal conditions.
Dr. Gerardo López Oseguera is an ophthalmologist and biomedical engineer specialized in anterior segment and retina surgery. He completed fellowships at the Instituto de Microcirugía Ocular (IMO) in Barcelona and holds an MBA in Health Innovation. Founder of Eyedictive, he focuses on developing novel surgical and diagnostic technologies, including the Oseguera Ring—a scleral fixation device for intraocular lens stabilization. His work bridges clinical practice and medical device innovation, with ongoing collaborations in preclinical validation and global ophthalmic research initiatives.
Giampaolo Gini is a general ophthalmic surgeon with a specific interest in retina.
He has been performing vitreo retinal surgery since 1990.
He is currently a substantive Consultant at University Hospitals Sussex NHS Trust with a specific role as vitreo-retinal surgeon while still maintaining an active private practice both in Italy and in the UK.
In the past he has covered several Consultant posts both for the Italian (SSN) as well as the British (NHS) National Health systems.
He has a considerable surgical experience with roughly 25.000 procedures on the anterior segment and 18.000 on the posterior segment of the eye. Because of this he has always been employed to deal with the more challenging cases on theatre lists.
Through the years he has developed a special interest in diabetes and ocular trauma surgery.
He is also known internationally as being one of the first surgeons to challenge the results of the Early Vitrectomy Study for the treatment of endophthalmitis. The paper published in 2006 (Vitrectomy for Endophthalmitis; Kuhn and Gini in “Ophthalmology”) helped pave the way for others to follow with their own experiences.
Dr Gini is an internationally recognised clinician, surgeon and educator.
He has received numerous international awards, among which the coveted Italian Ophthalmological Society Award (twice), the Royal College of Ophthalmologists’ Treacher-Collins Award and the American Society of Retina Specialists Reis-Buckler Award (twice).
He has frequently been involved in “live surgery” meetings both at home and abroad.
As a lecturer he has accumulated over 900 hours of activity in meetings in every part of the World.
He is an Associate Professor of Ophthalmology at Maimonides University Medical School (Buenos Aires, Argentina) and Visiting Professor of Ophthalmology at Yale University (New Haven, Connecticut, USA).
He has served as Board Member and Secretary of the European Vitreo Retinal Society of which he is currently President.
He has been named Liaison Officer to Europe for the American Society of Retina Specialists (ASRS) and is a Board Member of the Italian Association of Ophthalmologists (AIMO).
He has been a Faculty member of the European Vitreo Retinal Training School (Bremen), since its inception in 2001. This has resulted in contributing to the the training of over 1000 vitreo-retinal specialists.
Ever since his election to President of the European Vitreo Retinal Society (EVRS) he has also been actively involved in organising the Scientific Program of the Society’s Annual meeting (2017 Florence, 2018 Prague, 2019 Lisbon and the upcoming 2024 meeting in Budapest).
Particularly dear to him the invitation to deliver the Opening Lecture at the newly formed BEECS (British Emergency Eye Care Society) at Birmingham University in 2017 and the 2018 invitation to the annual meeting of the American Academy of Ophthalmology to lecture on the treatment of endophthalmitis.
He is a reviewer for multiple peer-reviewed scientific Journals.
He has contributed with a chapter in the book on Pediatric Vitreo Retinal Surgery (Springer Verlag) edited by Prof. Sengul Ozdek. He has also written several chapters and co-edited another book by Springer: Practical Manual of Vitreo Retinal Surgery.
Cabinet Dr Kamoun located at the Maghreb Medical Center, Specialist in ophthalmology and former intern at Tunis hospitals and the Adolphe Rothschild ophthalmological foundation in Paris.
Dr Kamoun contributes constructively to technological advances by carrying out several innovations in the field of ophthalmology and by actively participating in various national and international congresses.
His office is open to Tunisian and foreign patients for an optimal welcome and care in the image of Tunisia and Tunisian competence.
Hala Elhilali is a professor of Ophthalmology in Cairo University. She is the Vice-President of the Egyptian Association of Pediatric Ophthalmology and Strabismus (EAPOS) and President-Elect of the International Strabismological Association (ISA). She was the Director of the Pediatric Ophthalmology and Strabismus Unit in Cairo University (2015-2019). She has a special interest in pediatric and adult strabismus, pediatric glaucoma and pediatric cataract. She has participated in many international symposiums, webinars and courses and has numerous publications in the field of strabismus, pediatric cataract and glaucoma.
Current Position: 2021 – present Corneal, cataract & Refractive Surgeon Mediclinic Airport Road Hospital, Abu Dhabi. Professional Qualifications: 2019: Cert LRS Certificate of Laser & Refractive Surgery, Royal College of Ophthalmologists, London. 2015: CCT Certificate of Completion of Training (General Medical Council, UK – GMC reg no 7001533) 2013: FRCOphth. Fellowship of the Royal College of Ophthalmologists, London. 2012: PGCert. Cataract and refractive surgery. University of Ulster, Belfast. 2007: FRCS. Fellowship of the Royal College of Physicians & Surgeons, Glasgow. 2003: ICO certification. Basic, optics and clinical assessments of the International Council of Ophthalmology. 2000: MBBS. Bahauddin Zakriya University, Multan. Awards: •AAO Golden Ribbon 2010 •AAO Golden Ribbon 2011 •ASCRS Best Paper 2012 •ASCRS Best Paper 2012 •UKISCRS Best Paper 2011
Prof. Hani Sakla, consultant Ophthalmologist and head of Cataract, cornea and refractive surgery unit in Dubai Health Authority; Professor of Ophthalmology Dubai medical college. Founder and Director of Ebsaar Eye Surgery Center and Spanish Eye Clinic in Dubai.
Prof Hani is recognised for his work in the treatment of Keratoconus. He has published many peer reviewed papers and books on Refractive surgery, keratoconus, cataract, bioadhesives and presented at numerous international conferences.
Hany S. Hamza is a Professor of Eye Surgery at Faculty of Medicine Cairo University Egypt. He earned his medical degree at Cairo University Egypt and conducted his residency and fellowship at the same place. He then conducted a research retina fellowship at Wilmer Eye Institute, Baltimore Maryland in 1999. He also conducted a short fellowship program at the University of Essen in the field of intraocular tumors in 2004. Dr. Hamza specializes in the diagnosis and management of medical and surgical vitreoretinal diseases. His practice focuses on all aspects of surgical retina including retinal detachment , diabetic vitrectomy but also includes treatment of intraocular tumors using ruthenium radioactive plaques as well as retinopathy of prematurity and pediatric retinal surgery . Dr. Hamza served as the General Secretary of the Egyptian Vitreoretinal Society (EGVRS) from 2011 till 2017 and the President of the EGVRS during the period of April 2023 to April 2025 and is currently a member of the board . He is also on the board of the Afroasian Council of Ophthalmology. He is also the Head if the Ocular Oncology Service at Cairo University.
Dr. Huda Al Dhaheri is a consultant Cornea, Cataract & Refractive Surgeon at Tawam Hospital in Al Ain –UAE. She obtained her medical degree from UAE University and completed her residency training at king Saud University and Saudi Board in ophthalmology in 2013. She completed her advanced subspecialty training at King Khalid Eye Specialist Hospital ( KKESH) in Riyadh- KSA, where she joined Cornea, cataract and refractive surgery fellowship program. She received her FRCS degree from the Royal College of Surgeons of Edinburgh and fellowship of the international council of ophthalmology ( FICO) in in 2014 . Dr.AlDhaheri Joined Tawam Hospital in 2016 and established Cornea Services for Al- Ain Region.
Dr. Hussein Almuhtaseb is a distinguished Consultant Ophthalmologist specializing in Cataract and Vitreoretinal Surgery, whose career is marked by clinical excellence and a forward-looking commitment to technological advancement in medicine.
Following his residency at Sagrat Cor University Hospital in Barcelona Spain, Dr. Almuhtaseb further honed his expertise by completing four prestigious fellowships in Medical and Surgical Retina at leading institutions, including the University Hospital Southampton and the Manchester Royal Eye Infirmary. He subsequently served as a Consultant Ophthalmologist in Cataract and Vitreoretinal Surgery at North Manchester. In 2022, he established and led the Ophthalmology Department at The View Hospital in Doha, Qatar, a facility affiliated with Cedars-Sinai, solidifying his reputation as a leader in the field.
In addition to his surgical practice, Dr. Almuhtaseb holds a special interest in the application of Artificial Intelligence (AI) in Retina. He has actively pursued this passion, completing a certificate in AI in Healthcare: From Strategies to Implementation from Harvard University, positioning him at the intersection of advanced surgical technique and cutting-edge medical technology. His focus is on leveraging AI to enhance diagnostic accuracy, predict disease progression, and optimize treatment pathways for complex retinal conditions.
Dr. Kanellopoulos is an ophthalmic surgeon who specializes in the diagnosis and treatment of keratoconus, in refractive surgery with customization and the microsurgery of complicated cataract, as well as cornea transplantation in complicated glaucoma procedures.
His curriculum vitae comprises of: Medical degree from the Un of S. Illinois, Ophthalmology Residency at the State University of New York at Brooklyn, Cornea and Refractive Clinical fellowship surgery at Cornell Un / North Shore University Hospital, Surgical. Glaucoma Clinical Fellowship as well as Keratoprosthesis training with Claes Dohlman, MD, PhD at the Harvard Medical School, Massachusetts Eye and Ear Infirmary.
1996 Assistant Professor of Ophthalmology and Director of Residency Training for the State University of New York at Brooklyn, 2001 Associate and in 2010-present Clinical Professor of Ophthalmology NYU Medical School, New York City, NY.
He has presented over 1,000 original paper presentations at the major ophthalmology meetings: AAO, ASCRS, ESCRS and ARVO. He has published over 130 peer-reviewed papers, dozens of book chapters, as well as hundreds of editorials in ophthalmology-related commercial journals.
His continued research interests focus in customization of laser treatments early diagnosis and management of keratoconus, biological factors involved in corneal wound healing.
Dr. Kanika is a Vitreoretina Surgeon and Uveitis specialist currently working at Burjeel Day Surgery Center , Reem island, Abu Dhabi. She completed her Ophthalmology residency from the prestigous Postgraduate Institute Of Medical Education and Research ( PGIMER), Chandigarh, India. She completed her Surgical fellowship and training at the same institute (PGIMER, India). She has over 65 indexed peer-reviewed publications and has authored more than 5 book chapters. Her primary areas of interest include diabetic retinopthy, surgical diseases of the retina and uveitis.
Dr. Khaled Abuhaleeqa MBBS ,BCh,Bao FRCSC , Is a Staff physician in the Eye Institute at Cleveland Clinic Abu Dhabi
He has 22 years’ experience in the medical field, with more than 10 in his subspeciality of plastic ophthalmic and reconstructive surgery and Neuro – Ophthalmology. HE has Many publications including peer reviewed articles and book Chapters in theses fields . He is appointed as Adjunct Clinical Assistant professor at the prestigious College of Medicine and health Sciences , Khalifa University
He is a board certified and fellowship trained consultant ophthalmologist, having earned his medical degree from the Royal College of Surgeons in Ireland in 1998. He completed his internship and became member of the Medical Association in Ireland the following year. Dr Abuhaleeqa received his Ophthalmology residency training at the University of Toronto in Ontario, Canada. He also has completed three fellowship programmes, one in Oculoplastics, Strabismus and Neuro-ophthalmology from the University of Toronto and the other fellowship in Ophthalmic Plastic and Reconstructive Surgery from McMaster University, Hamilton. The third fellowship was in Ophthalmic and Orbital Oncology again at McMaster University . . Dr Abuhaleeqa has speciality certification and fellowship designation from the Royal College of Surgeons in Canada. He is the first UAE citizen with speciality in these fields.
Prior To Joining Cleveland Clinic Abu Dhabi , Dr Abuhaleeqa was The chief of Ophthalmology service at Sheikh Shakhboot Medical City ( In Partnership with Mayo Clinic USA ) , He has also been working in Abu Dhabi SEHA network for 20 years . In Addition Dr Abuhaleeqa worked as an independent Doctor at Mediclinic Health Network in The UAE .
He is the vice president of The Emirates Society of Ophthalmology.
He is currently accepting appointments for patients needing services in plastic, ophthalmic and reconstructive surgery, including cosmetic and aesthetic procedures, lacrimal system disorders, orbital trauma, neuro-ophthalmology and Orbital oncology.
A Lecturer of ophthalmology in Fayoum University. Anterior segment consultant in International Eye Hospitals Egypt.
Anterior segment consultant in Magrabi Hospitals of Egypt from April 2005- December 2006.
Specialist of Ophthalmology in Research Institute of Ophthalmology from May 1995 – August 2004.
Member of American and European Societies of Cataract and Refractive Surgery.
Experience of doing more than 2000 cornea surgery, 20000 cataract surgery (phacoemulsification) and more than 5000 LASIK surgery.
Intensive experience in working with Alcon phacoemulsification machines especially the Infiniti machine.
Active member in the board of Egyptian cataract and refractive surgery society.
Organizing the courses for learning and passing skills to others regarding the anterior segment surgeries.
Consultant to Alcon company in Egypt and middle east. Educating doctors regarding phacoemulsification machines and surgical techniques. And researcher for the development of phacoemulsification machines for Alcon phacomachines.
Sharing experience in more than 25 live surgeries in phacoemulsication in Egypt and middle east countries.
Dr. Laila Ababneh is a Consultant Pediatric Ophthalmologist and Strabismus Surgeon at Sheikh Khalifa Medical City, Abu Dhabi. She completed her higher specialty training at the Jordan University of Science and Technology and a fellowship in Pediatric Ophthalmology and Strabismus at the University Hospital of Göttingen, Germany. Formerly Head of Ophthalmology and Residency Program Director at King Abdullah University Hospital. Her clinical interests include strabismus, congenital cataract, retinopathy of prematurity, oculoplastic surgery, and myopia control.
Mr Leon Au is a Consultant Ophthalmic Surgeon specialising in glaucoma and cornea. He graduated from the University of Nottingham in 1998 with an ophthalmology prize of the year. He completed 8 years of general ophthalmology training in Nottingham and Manchester before undertaking separate subspecialty training fellowships in cornea, glaucoma and refractive surgery. He has been a dual-specialty consultant in the Manchester Royal Eye Hospital since February 2009. He is an international leader in the field of innovative glaucoma surgeries and is involved in many of the clinical trials
Dr. Livia Lumbroso-Le Rouic is an ophthalmologist specializing in ocular oncology. She serves as a senior physician at the Institut Curie in Paris, one of Europe's leading cancer centers. Dr. Lumbroso-Le Rouic focuses primarily on the diagnosis and treatment of eye tumors, including uveal melanoma and retinoblastoma. Her work combines clinical care with research, aiming to improve therapeutic outcomes and preserve vision in patients with ocular cancers. She is also involved in academic teaching and has contributed to numerous scientific publications in her field.
Dr. Luai Eldweik is a Staff Physician at the Eye Institute, Cleveland Clinic Abu Dhabi. He completed a fellowship in Neuro-Ophthalmology at the University of Minnesota, Minneapolis, USA, and a fellowship in Pediatric Ophthalmology and Strabismus at Harvard Medical School, Boston, Massachusetts, USA.
Dr. Eldweik’s clinical practice focuses primarily on neuro-ophthalmology, including the evaluation and management of optic neuropathies, idiopathic intracranial hypertension, visual field defects, double vision, ocular motor disorders, and neuro-inflammatory diseases. He also manages complex adult and pediatric strabismus, emphasizing individualized, evidence-based surgical and non-surgical care.
In addition to his clinical work, Dr. Eldweik is actively involved in teaching and research, with particular interest in optic neuritis, papilledema, and the use of optical coherence tomography (OCT) in neuro-ophthalmic disorders.
Luís Abegão Pinto is the Head of the Glaucoma Clinic of the Department of Ophthalmology of Portugal's largest Hospital (Hospital Santa Maria). He serves as Associate Professor of Ophthalmology at the Faculty of Medicine of Lisbon University, Portugal. His main areas of interest are Glaucoma Surgery, Artificial Intelligence and Screening.
He serves in the Executive Board of the European Glaucoma Society (EGS) since 2018 and he is currently the EGS Vice President. Moreover, he is co-chair of the EGS TaskForce on Glaucoma Surgery, co-editing the new "Guides on Innovations in Glaucoma Surgery" He has authored or co-authored 105 indexed, peer-reviewed papers in Glaucoma. He is actively engaged in several scientific ophthalmological societies, including the EGS and EVER, having chaired or co-chaired a number of courses in international Ophthalmology societies' meetings.
Professor (Dr.) Mahipal. S. Sachdev, Chairman & Medical Director of Centre for Sight is a renowned ophthalmic Surgeon who is recognized for his expertise in the area of Cataract, Refractive & Corneal Surgery, both nationally and internationally. He was honored with Padmashri award on January 26, 2007. In the year 2017, he attained Professorship in Ophthalmology & in year 2020 has been elected as President of All India Ophthalmological Society. He is widely credited to be pioneer in India in propagating the technique of Phacoemulsification for cataract surgery and Lasik Laser for removal of glasses.
In 1996, Professor (Dr.) Mahipal Sachdev stepped out of AIIMS with a dream of creating a world class eye hospital. “Centre for Sight” is an outcome of that.
Professor (Dr.) Mahipal is a visionary and leader. He has always been the torchbearer in the field of eye care pioneering several procedures including laser assisted blade less surgery for cataract and Lasik. Prof. Mahipal learned about “Phaco” (Stich less micro incision cataract surgery) while pursuing his fellowship in United States. He knew it was next big thing in ophthalmology. Prof. Mahipal was among the first to introduce Lasik and Phakic IOLs & Femtosecond laser technology for lasik. Prof. Mahipal also has pioneered blade free Femtocatarct technology in India.
He has authored over 5 books on cataract & Refractive surgery including the first book on phaco by an Indian Ophthalmologist. These books are today referred to by every budding Ophthalmologist. Prof. Mahipal is an active contributor of articles on eye health in mass media for the benefit of the general public also.
He has been recognized globally with fellowships and scholarships from the “Fifth International Symposium on Immunopathology”- Japan, “International Society of Eye Research”, “Research to Prevent Blindness”, New York, “Fisons award by the Contact Lens Association of Ophthalmologists”, USA amongst others. In India he has won the “A C Aggrawal Memorial Trophy”, “Col. Ranagachary Certificate”, “Krishna Sohan Singh Trophy”, “Dr Ishwar Chand Silver Jubilee Award” to name a few. Prof. Mahipal Sachdev has recently been awarded “Dr. S.N. Mitter Oration award” in DOS conference held in April 2017”. Prof. Mahipal has also received “Life Time Achievement Award- Ophthalmology” at Times Health Care Achievers program held in Delhi. To add on Prof. Mahipal was honored with a Gold Medal in KOSCON conference 2017 in Bengaluru.
Prof. Mahipal is an actively involved in Research & Development, he has been instrumental in the Development of the ELITA Femtosecond laser by J&J. He was the PI of the First-in-man clinical trials for the ELITA. He is also the first person in the world to perform the Flap as well as the Lenticule extraction procedure (SILK) on the ELITA platform.
Prof. (Dr.) Mahipal S. Sachdev was honored with Padamshree Prof. Dr. TP Lahane Award Award at MOSCON 2022. Further, he was honored with Dr. Hari Mohan Oration 2022 in 73rd DOS Conference at New Delhi. He is presently also member of the Global Advisory Board, J & J. Prof. Sachdev was felicitated with the APACRS Certified Educator (A.C.E) award, and was also awarded appreciation as the IIRSI representative, at the APACRS 2023, Singapore.
Prof. (Dr.) Mahipal S. Sachdev was awarded Hero of Ophthalmology award in KSOS 2023 at Thrissur, Kerala. Further, he was honored with Honorary Doctorate (D.Sc. Honoris Causa) at 19th Annual Convocation of the University held on 08 Dec 23 (Friday) at Amity University, Uttar Pradesh (AUUP), Noida.
Prof. (Dr.) Mahipal S. Sachdev has been conferred with the prestigious “AIOS – Dr. LP Agarwal Endowment Lecture 2024 and Achievement Award at AIOC 2024 held from 14 -18 Mar 24 at Kolkata, West Bengal and “ISCKRS Refractive Oration Award at ISCKRS Annual Conference held from 02 -04 Aug 2024 at New Delhi.
Prof. (Dr.) Mahipal S. Sachdev has been awarded with the prestigious “Asu Biswas Kanika Biswas Oration Award at Conference held on 11 Aug 2024 at Trenetralaya, Kolkata, West Bengal. Prof. (Dr.) Mahipal S. Sachdev has been awarded with the prestigious “Legend in Ophthalmology Award at Conference held from 03 -05 Jan 2025 at MM Joshi Eye Institute, Hubli, Karnataka. Prof. (Dr.) Mahipal S. Sachdev has been awarded with the prestigious “RP Centre Oration Award on 58TH RP Centre Foundation Day on 10 Mar 2025 at Delhi. Recentley, Prof. (Dr.) Mahipal S. Sachdev has been awarded with the prestigious “Senior Achievement Award at AIOS APAO Conference 2025 on 05 Apr 25 at Delhi.
Prof. (Dr.) Mahipal S. Sachdev is a rare combination of a brilliant surgeon, an entrepreneur and above all, a compassionate human being. He has ensured that the Indian Flag remains flying high in the domain of eye care and that the patients in India have access to the best and the latest when it comes to treating their eyes in line with his own mission statement “…. every eye deserves the best”.
Dr. Mahmood Showail is an Assistant Professor at the department of Ophthalmology, King Abdulaziz University and a Cornea, Anterior Segment and Refractive Surgery Consultant at King Abdulaziz University Hospital in Jeddah, Saudi Arabia. He is also the chief of Ophthalmology at the International Medical Center (IMC) in Jeddah, Saudi Arabia. Prior to this, he served as the medical director of Magrabi Al-Murjan Eye complex in Jeddah and was a staff Ophthalmologist and a cornea surgeon at Oakville Trafalgar Memorial Hospital in Oakville, Canada. Dr. Showail earned his Bachelor’s Degree in Medicine and Surgery from King Abdulaziz University. He went to University of Toronto in Canada for his residency training and obtained his FRCSC degree from the Royal College of Physicians and Surgeons of Canada. He completed his Cornea, External Disease and Refractive Surgery fellowship at the University of Toronto followed by another year of fellowship in Pediatric Cornea and External Diseases at the world renowned Hospital for Sick Children (SickKids) in Toronto. Dr. Showail is a founding member of the Saudi Group of Cornea and Refractive Surgery. He sits on the review board of many leading peer-reviewed Ophthalmology journals. Dr. Showail has numerous publications in prestigious journals including Cornea, American Journal of Ophthalmology, Canadian Journal of Ophthalmology and Journal of Refractive Surgery.
Michael Assouline, MD, PhD, FEBO Ophthalmic & Refractive Surgeon Founder & Medical Director Centre Ophtalmologique Iéna Vision 37 rue Galilée 75116 Paris, France www.ienavision.fr Clinique de la Vision 131 rue de l'Université 75007 Paris, France Mikajaki SA, Route de la Galaise 34 Plan-les-Ouates (Geneva) CH – 1228 Switzerland www.mikajaki.com Michael Assouline, MD, PhD, FEBO, trained as a resident and a cornea fellow in Paris and in the USA. He held a number of positions in University Hospitals in Paris. In private practice since 1997, Dr Assouline founded the IénaVision Eye Center in Paris in 2010 (www.ienavision.fr). He also co-founded the Clinique de la Vision in Paris, still the leading Refractive Surgery Center in France (www.cliniquevision.fr). In 2018 he co-founded MIKAJAKI, a Geneva based company which developed the EyeLib ophthalmic Suite composed of a robotic ophthalmic diagnostic station (CE Mark obtained in september 2020, ISO certified June 2021), a conversational virtual agent diagnostic tool, and a full range multimodal AI powered Smart-Vision Report™. Over the last 30 years, Dr Assouline gave more than 400 lectures in 54 countries. He published 35 papers in peer-reviewed journals, 24 book chapters, and more than 150 professional articles.
Dr Mohamed ALKETBI is a young consultant ophthalmologist who recently joined SKMC hospital in the field of surgical retina and uveitis. Graduate of an MBBS program from GMU, Ajman. He pursued his further studies in FRANCE and completed his residency in ophthalmology at the University hospital of NICE, FRANCE, during which he participated in many research and publication activities and joined one humanitarian mission to CONGO in 2017. He also has done a two-year fellowship in surgical retina and uveitis at the same centre in France. This fellowship training gave him a good insight and clinical exposure to many cases and treatment modalities in the field of surgical retina and uveitis. The University Hospital of Nice, France, praises itself as being one of the most known centres in France and Europe for Ocular Oncology, Dr Alketbi have had the chance also to work with such cases with a graduation Memoire titled “ocular secondary metastasis.
Amine Belarbi is a recognized innovator in Al and technology, celebrated as "Young Entrepreneur of the Year" by Arabian Business, named among the "Top 10 African Change Leaders" by the African Leadership University, and the youngest entrepreneur featured on the cover of Forbes Middle East.
He is the Founder and CEO of Project Cypher, one of the fastest-growing cybersecurity companies in the region, helping tech giants and leading brands across the GCC, North Africa, and the USA defend against cyber threats. Project Cypher emphasizes R&D and product innovation, with its flagship platform, Cypherleak, launched in January 2022 and now serving over 1 ,OOO corporate customers globally.
Amine also co-founded Halahi.com, a platform connecting fans with personalized video messages from hundreds of global celebrities and influencers, reaching a combined audience of nearly 400 million.
He is the author of the Amazon bestseller The Art of the Grind: What They Don't Teach You in College and the Spanish book PANGEA: Siete jövenes que estan transformando el mundo, sharing his insights on entrepreneurship, technology, _i and innovation.
Dr Mohamed Hosny, MD,FRCOphth,FRCSEd
Upon completion of ophthalmology residency in 1997 , Dr Hosny worked as a fellow of refractive and anterior segment surgery at the University of Alicante ,Spain perusing the clinical research of his Doctorate thesis under supervision of Professor Jorge Alio. He then travelled to work as a Registrar of Ophthalmology at Princess Alexandra Eye Pavillion in Edingburgh for one year. He obtained his Masters Degree from Cairo University in 1996 , His FRCS degree from the Royal College of Surgeons of Edingburgh in 1998 ,and his Doctorate degree in 1999.Dr Hosny was Elected as Fellow of the Royal College of Ophthalmologists in 2022.Dr Hosny has numerous international publications including coauthoring in David Ben Ezra’s book “ Ocular inflammation”, Professor Cristobal’s book “ Management of Astigmatism” as an official textbook of the Spanish Society of Ophthalmology and Professor Mazotta’s “ Corneal Crosdlinking”.Dr Hosny is a regular presenter at the ASCRS and the ESCRS meetings over the past 20 years.He served for more than 14 years as panelist and co-Chair person in sessions at the annual meeting of the ASCRS.Dr Hosny serves as an Elected board member in the Egyptian Society of Ophthalmology and The Egyptian Society of Ocular Implants and Refractive Surgery . He is currently the Vice President of The International Keratoconus Society and the Vice President of the Dry Eye and Ocular Surface Society. He serves among the editorial board member of the International Journal of Keratoconus and Corneal Ectatic Diseases. He is an Examiner at the Royal College of Ophthalmologists fellowship Exams as Well as the Royal College of Ophthalmologists Certificate for Laser and Refractive Surgery Exam as well as the Arab Board of Ophthalmology.
Dr Hosny is currently a Professor Of Ophthalmology at Cairo University , he also is a leading Refractive and Anterior segment consultant at Dar El Oyoun Specialized Eye Hospitals in Egypt.
Dr. Mohammed Majed Abusayf is an Assistant Professor and Consultant in the Cornea, Cataract, External Ocular Disease, and Refractive Surgery Unit, Department of Ophthalmology, at King Saud University, Riyadh, Saudi Arabia. He has received training from respected institutions, including King Khaled Eye Specialist Hospital (KKESH), King Saud University (KSU), the Singapore National Eye Center (SNEC), and Duke-NUS Medical School. Additionally, he completed a research fellowship at the Singapore Eye Research Institute (SERI), focusing on tissue engineering, cell therapy, and femtosecond laser application in corneal diseases.
Specializing in corneal, refractive surgery, and complex cataract surgeries, he contributes to clinical practice and has a great appetite for research. Dr. Abusayf has published several papers and presented at local and international conferences. He is also dedicated to medical education and volunteer work.
Dr. Mohammed Al-Mutlak is a Consultant in Cornea, External Disease, and Refractive Surgery at King Khaled Eye Specialist Hospital (KKESH) in Riyadh, and Head of the KKESH Eye Bank.
Dr Muhammad A Ahad, FRCS, MRCOphth, PhD, is a Senior Academic Consultant and Chair of the Anterior Segment Division at King Khaled Eye Specialist Hospital in Riyadh. He also serves as an Adjunct Associate Professor at AlFaisal University, Riyadh. With extensive expertise in ophthalmology and academic leadership, Dr Ahad is recognized for his contributions to advancing clinical practice and education in anterior segment surgery.
Muhammad Younis, MD, FACS
Consultant Ophthalmic SurgeonPediatric Ophthalmology and Adult Strabismus
Dr. Muhammad Younis is a graduate of the American University of Beirut (AUB), where he earned his Bachelor of Science in Biology followed by his Doctor of Medicine degree. He then completed his residency in Ophthalmology at the same institution.
He pursued two years of fellowship training in Pediatric Ophthalmology and Adult Strabismus at Moorfields Eye Hospital and the Hospital for Sick Children, University College London. He also served in an academic post as Specialist Senior Registrar at St. James's University Hospital and Leeds General Infirmary in Northern England.
Upon returning to Beirut in 1998, Dr. Younis established his private practice and joined the American University of Beirut Medical Center and other major university hospitals as Consultant Ophthalmic Surgeon an academic affiliate, where he continues to teach residents and medical students. His academic and clinical focus centers on Pediatric Ophthalmology and Adult Strabismus.
Dr. Younis served as President of the Lebanese Ophthalmological Society (2009–2011) and has been a National Board Member of the Middle East African Council of Ophthalmology (MEACO) since 2006, where he currently chairs the Pediatric Ophthalmology and Strabismus Committee.
He is currently the Head of the Ophthalmology Department at Clemenceau Medical Center Dubai, affiliated with Johns Hopkins International, and serves as President-Elect of the American College of Surgeons – Lebanon Chapter.
Since 2010, Dr. Younis has also been an active Board Member of the Scientific Committee Bureau of the World Society of Pediatric Ophthalmology and Strabismus (WSPOS).
Dr. Younis has organized and participated as an invited speaker in numerous national, regional, and international scientific meetings. He has authored several publications in peer-reviewed journals and serves as a reviewer for multiple scientific periodicals.
His ongoing academic interests include strabismus surgery, botulinum toxin use, pediatric cataracts, amblyopia management, myopia control, and vision screening programs.
Dr. Murad Alobthani, MBBS, FRCS(Canada)
Dr. Alobthani did the residency training at University of Toronto, Canada and graduated from the Royal College of Surgeons Canada. He completed cornea and refractive surgery fellowship at University of British Columbia, Vancouver, Canada followed by a second Corneal fellowship at Moorfields Eye Hospital in London, UK.
Dr Nada Al-Yousuf is a Bahraini ophthalmologist graduated from Arabian Gulf University in Bahrain and completed her residency at the Royal Infirmary of Edinburgh, Princess Alexandra Eye pavilion in Scotland. She is a fellow of the Royal College of Surgeons of Edinburgh and completed her Cornea and anterior segment Fellowship at The Corneo-plastic Unit and Eye bank in Queen Victoria Hospital in East Grinstead in the UK. Dr Al-Yousuf is the founder and Director of the first Amniotic membrane eye bank in the Gulf countries in 2004. She has over 30 years experience in anterior segment surgeries focusing of cataract, cornea transplant and ocular surface. Her experience included training and supervising residents and fellows at Salmaniya Medical Complex in Kingdom of Bahrain.
Besides her clinical practice, Dr Dr Al-Yousuf served as an Assistant professor at The Royal College of Surgeons of Ireland.
She is currently Consultant Ophthalmologist and cornea surgeon , and chairperson of Ophthalmology department at The University Medical Center and an Associate Professor at The College of Medicine, Arabian Gulf University, in Kingdom of Bahrain.
Dr. Nicola George Ghazi is an American Board Certified Ophthalmologist who subspecializes in ophthalmic pathology and vitreo-retinal diseases and surgery. He is currently the medical director of the Bascom Palmer Eye Institute in Abu Dhabi.
Dr. Ghazi has many years of experience in eye and retinal surgery as well as the treatment of eye cancers. Through his previous academic career, he attained the rank of Clinical Professor of Ophthalmology at the Cleveland Clinic Lerner College of Medicine of the Case Western Reserve University in Cleveland Ohio, USA and was a consultant for retinal diseases and surgery at Cleveland Clinic Abu Dhabi, UAE where he also served as Department Chairman, posterior segment at the Eye Institute. He was also a Clinical professor of Ophthalmology at the Gilbert and Rose-Marie Chagoury School of Medicine at the Lebanese American University, Beirut, Lebanon where he also served as the Chairman of the ophthalmology department.
Dr. Ghazi also has extensive experience in research and education. His clinical and research work has focused on the fields of retinal surgery, retinal imaging, and treatment of retinal diseases. Dr. Ghazi is the author of numerous published research articles, abstracts, and book chapters. He has delivered many presentations, among which were numerous invited lectures, at regional, national and international meetings across the world. He is a member of many national and international ophthalmic organizations and a reviewer for numerous ophthalmic journals. His dedication to clinical excellence, patient experience, research and medical education lead to his recognition by many honors and awards.
Professor Dr Nihal Al Shakankiri is a Professor of Pediatric Ophthalmology in Faculty of Medicine, Alexandria University in Egypt. She completed her undergraduate studies in Alexandria University and obtained her Bachelor Degree in 1989. She completed Ophthalmology residency in Alexandria Main University Hospital to obtain a Master Degree in Ophthalmology in 1994, and then her Doctorate Degree in Ophthalmology in 2000. She was then appointed to join the faculty staff where she finally became Professor of Ophthalmology in 2010. She developed a special interest in Pediatric Ophthalmology in the year 1995 to mark her first steps with a Doctorate Degree thesis about the evaluation of heparine surface modified IOLs in children. She then continued a life long commitment to Pediatric Ophthalmology by a series of research topics in different aspects of Pediatric Ophthalmology with special interest in pediatric cataract. Some of her publications appear in International journals as Ophthalmology, Journal of Cataract and Refractive Surgery and journals in the domain of molecular and clinical genetics. In 2007 she founded the Association of Children Eyes of Alexandria, a non profit organization concerned with fund raising to sponsor every possible activity related to children eyes. This brought a quantum leap marked by founding and inauguration of Pediatric Ophthalmology Unit in Alexandria University, a place fully equipped with the most up to date instrumentation and technology related to the care of eyes of children. She participated in meetings all over Egypt and some outside Egypt teaching and lecturing and giving courses in Pediatric Ophthalmology, particularly pediatric cataract. She has lectured in Lausanne (Switzerland) in 2009, Beirut in 2010, Tunisia in 2011 and in 2013, Nigeria ( MEACO pediatric cataract course) in 2011, New York( International symposium of pediatric cataract) in 2011 and in 2014. In year 2015 she lectured in Barcelona (World Society of Pediatric Ophthalmology and strabismus ).In year 2017 she participated in the World Society Pediatric Ophthalmology and strabismus in India by video presentations. In year 2018 she gave a course in management of congenital cataract in Saudi Arabia and Lebanon. In Ethiopia in Addis Ababa in 2018 in COESCA meeting she gave a lecture in management of ectopia lentis in children. In 2019 she gave a lecture in Tunisia in management of ectopia lentis .She gave a course in management of congenital cataract in COESCA meeting in 2019 in Rwanda. In Kuwait she gave lectures in pediatric cataract in 2019 and finally she gave a course and a lecture in congenital cataract in Dubai in the 5th QOIC 2020 meeting.
To Nihal Al Shakankiri, prevention of blindness in children is her whole world.
Dr Noura Almansoori, is a Emirati consultant ophthalmologist specialized in medical retina and vitre-retinal surgeries. She is working currently in Samaya specialized Center Abudhabi, and she is the deputy Medical director . She finished her fellowship of Medical and surgical Retina in University of Montreal , Canada where she accomplished all varieties of complex surgical procedures. She received multiple high achievements awards during residency and fellowship. She is well recognized as the only Emirati female consultant Vitreo-Retinal surgeon currently on practice.
Dr. Owaidhah is a senior consultant & Chair of IRB Committee at King Khaled Eye Specialist Hospital (KKESH), Riyadh, Saudi Arabia, adjunct assistant professor at AlFaisal University. She is also the chair of the Saudi Glaucoma group and an editorial board member for Glaucoma section at EyeWiki website and the first surgeon to implant XEN implant in Saudi Arabia. She received the award of "Exceptional Physician" at May 2015 & an award from HRH Prince Abdulaziz Bin Ahmad AL-Saud for chairing "World Sight Day" activities at the Kingdom.
– Omnia Hamam, MD, DES is a Consultant Ophthalmologist in Zayed Military Hospital. Fellowship in Glaucoma and Retina from Pierre and Marie Curie University Paris. She is also an Adjunct Assistant Professor in the UAE University and Head of Scientific Committee in Emirates Society of Ophthalmology. – She is French board certified, Worked during 5 years in different university hospitals in Paris, followed by 2 years in Quinze Vinghts hospital – The second biggest eye center in Europe. She was apart from research team in ocular surfaces and glaucoma disease in Institute du vision in Paris. She has given many lectures in National and International Congress. She also obtained four University Diplomas such as: DU in Glaucoma 2015; DIU in Retinal Imaging and Pathology 2014; DIU of Neuropthalmology 2012-2013; DIU Ocular Inflammation and infection 2009-2010. – In relation to her field, she has the eagerness to learn and interested more particularly in Ocular Imaging. Through her capabilities, she is performing a series of courses and workshops about Ocular Imaging Techniques and Interpretation, Optical Coherence Tomography Angiography in Retina, Ocular Echography, Visual field of Retina, Optic Nerve Imaging, Ocular Radiology etc. She mainly believes that learning is a process to guide her through her journey.
Clinic: Jenna Ophthalmic Center, Baghdad / Iraq Subspecialty: Cataract & refractive Qualification : FRCophth.(glasc.) Affiliated to: Jenna ophthalmic Center (joc) FRCS (glascow)ophthalmology 2002 Manager of phacoemulsification training courses held in ibn-alhaitham eye teaching hospital 2005 Founder and manager of Jenna ophthalmic centre 2016. Founder and former president of Iraqi society of cataract and refractive surgeons.2018 Founder and co-chairman of MOCAT(Mesopotamia ophthalmology conference for advanced techniques)
Anterior segment surgeon, since 1994 – specialized in cataract, refractive and corneal transplant surgery
Posterior segment surgeon, since 2020
Eye Surgeon and co-manager in Oculus Eye Clinic – Bucharest
Affiliation: Co-opted member of the ESCRS Board and of the ESCRS Educational Committee (2012 - 2016 – attending all the ESCRS Board meetings in 2012-2016
ESCRS Academy member – since January 2014, ongoing; invited speaker for several Academy meetings
ESASO Faculty member – since January 2014, ongoing; invited course presenter for ESASO
Surgical experience (1994 – present): approx. 70000 cases of cataract surgery with PC-IOL implantatation (mostly phaco procedures; experience in astigmatism and presbyopia correcting lenses and in Femto-Assisted Cataract surgeries, since 2013
approx. 2000 cases of corneal transplantation and combined procedures
approx. 500 vitreo-retinal surgeries
experience in office-Laser procedures (YAG capsulotomies, iridotomies, ALT/SLT)
Speaker for several congresses and meetings in national and international congresses (including several editions of ASCRS, ESCRS 2006-2025, SICSSO 2017-2021, Videocatarattarefrattiva, 2010 - 2025), AICCER 2021 and 2024, Koln Advent Symposium 2022, EuCornea 2022 - 2023, GIVRE 2023, MEACO- AAO session 2023, ESOIRS 2024.
Experience in national and international Live surgery sessions, as surgeon: several times in ESCRS meetings, in MTK congresses, HSIIRS meetings, ESASO meetings and others, between 2006 and 2019
Experience in International clinical studies, GCP certified, since September 1999 to present
Books: "Cataract surgery complications" – Lucio Buratto, Stephen Brint – SLACK Incorporated, 2013 – Chapter: Complications of Phacoemulsification and „Practical guide for avoiding and treating complications in cataract surgery" – Curtea veche Publisher, 2019
Prof. Piergiorgio Neri, BMedSc, MD, PhD, FEBOphth, MBA, is a globally recognized authority in ocular immunology and inflammation, widely respected for his pioneering contributions to translational medicine, immune-pharmacology, and precision-guided therapeutic strategies in complex intraocular inflammatory disorders. With a multidisciplinary background that spans clinical medicine, neuroscience, and executive leadership, Prof. Neri offers a uniquely integrated approach to patient care, scientific research, and academic advancement in ophthalmology.
He graduated summa cum laude from the University of Ancona Medical School in 2000, obtained a specialist diploma in ophthalmology from the Polytechnic University of Marche in 2004, and earned a PhD in neuroscience in 2007 with a dissertation focused on immunosuppressive therapy in ocular inflammation. In 2023, he completed an MBA with high honors at Boston University Questrom School of Business and was inducted into both the Beta Gamma Sigma and Sigma Xi honor societies for academic excellence and research distinction.
Prof. Neri currently serves as Clinical Full Professor of Ophthalmology at the Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, where he plays an active role in medical education and academic governance. At Cleveland Clinic Abu Dhabi, he is Director of the Uveitis Service and Senior Advisor for Physician and Patient Experience, having previously served as Executive Medical Director of the Patient Experience Department. He holds institutional leadership positions on several enterprise-level committees, including the Clinical Coordination Committee, Operating Council, and the Digital Innovation Committee.
His earlier tenure at Ospedali Riuniti di Ancona included directing the Ocular Immunology Unit from 2007 to 2018, where he developed one of Italy's foremost tertiary referral centers for intraocular inflammation. During this period, he was also Assistant and then Associate Professor of Ophthalmology at the Polytechnic University of Marche, mentoring generations of medical students, residents, and doctoral candidates. Prof. Neri is internationally regarded for his expertise in translational research, particularly in bridging immunopathology, molecular pharmacology, and therapeutic innovation in uveitis. His deep understanding of immune-pharmacologic mechanisms, combined with his clinical insight, has positioned him at the forefront of biologic therapy development and immunosuppressive strategies tailored to individual patient profiles. He has led pioneering work in the integration of imaging biomarkers, systemic markers, and therapeutic monitoring to optimize outcomes in non-infectious uveitis and related systemic inflammatory conditions.
He is currently Editor-in-Chief of International Ophthalmology and Associate Editor of Ocular Immunology & Inflammation, and serves on the editorial board of the Journal of Ophthalmic Inflammation and Infection. Prof. Neri has authored more than 190 peer-reviewed articles and book chapters, with a publication record that reflects his core interests in translational immunology, autoimmune disease mechanisms, and evidence-based treatment algorithms.
Prof. Neri has also been actively involved in shaping health policy and drug regulation, having served for a decade as a board member of the European Medicines Agency (EMA) and the Italian Medicines Agency (AIFA), where he contributed to the Committee for Human Medicinal Products (CHMP). His experience in regulatory science has reinforced his commitment to responsible innovation and safe implementation of novel therapies. Fluent in English and Italian, Prof. Neri continues to mentor young clinicians and scientists, lead collaborative research initiatives, and serve as a thought leader in academic and clinical forums worldwide. His vision combines scientific rigor, clinical excellence, and patient-centered care, with the overarching goal of advancing precision medicine in ophthalmology and beyond. Prof. Neri also proudly serves as Chairman of the Scientific Committee of the Emirates Society of Ophthalmology (ESO), where he leads the strategic planning and academic direction of the Society's educational and scientific programs. In this role, he is dedicated to fostering innovation, international collaboration, and evidence-based learning across the ophthalmic community in the UAE and the broader region. His leadership reflects a deep commitment to advancing clinical excellence, integrating research, and promoting global engagement in ophthalmology.
DR. PRASAN RAO, FRCSEd (UK), MS (Ophthal), DipNB, FCPS, DO, DOMS, MBBS Vitreoretina Fellowship, Sankara Nethralaya (Chennai) Current position: Medical Director, Specialist Ophthalmologist & Vitreoretinal Surgeon, Medcare Eye Centre. Registration, Certification and Memberships: European Vitreoretinal Society Since 2008 American Academy of Ophthalmology Since 2004 All India Ophthalmological Society Since 2001 Vitreoretinal Society of India Since 2001 Maharashtra Ophthalmic Society Since 2002 Bombay Ophthalmologists’ Association Since 1999 Indian Medical council Unrestricted license to practice in India Navi Mumbai Raigad Ophthalmologists’ Since 2002 Association Indian Medical Association Since 2002 Emirates Medical Association Since 2004 American Society of Retina Specialist Since 2013. Awards & Distinctions: 1. Distinctions in 3rd MBBS in Ophthalmology & ENT, Preventive & Social Medicine. 2. International Ophthalmologist Education Award (IOEA) from American Academy of Ophthalmology in 2009 3. Vikas Ratna Shiromani Award – for excellent achievement and selfless service in his field. 4. International Ophthalmology Scholar Award (IOSA) from American Academy of Ophthalmology in 2012. 5. Oscar Award – Surgical Video Conference – EPOMEC 2019
Dr Ramesh Kekunnaya is the Network Director – Technology Innovation at LVPEI. The other major portfolios that he is handling include Director of the Child Sight Institute, Director of Centre for Technology Innovation, and Head - Jasti V Ramanamma Children's Eye Care Centre at LVPEI. Dr Kekunnaya is also an Executive Bureau Director of the World Society for Paediatric Ophthalmology and Strabismus (WSPOS), Founder Executive Bureau member of Paediatric Ophthalmology and Strabismus Network (POSN) of India, and an Administrative Council Member of the International Strabismological Association (ISA).
Dr Kekunnaya received his basic medical training from the Karnataka Medical College, Hubli, and specialized in ophthalmology from the Government Medical College, Mysore. He completed a fellowship in Paediatric and Neuro Ophthalmology, Strabismus and Comprehensive Ophthalmology at LVPEI, followed by a Paediatric Ophthalmology and Strabismus Fellowship (AAPOS accredited) at the Jules Stein Eye Institute, University of California, USA. His core clinical interests include simple and complex strabismus in adults and children (squint), childhood cataract, vision development, myopia, amblyopia (lazy eye) and neuro-ophthalmological disorders in children.
He has been honoured with Achievement Awards from the American Academy of Ophthalmology (AAO) and Asia Pacific Academy of Ophthalmology. Dr Kekunnaya is also the recipient of the International Scholar Award and International Education Award from AAO, and Honor Award from the American Association for Pediatric Ophthalmology and Strabismus.
Dr Kekunnaya has authored over 150 publications in peer-reviewed journals in addition to having written over 25 text book chapters. He is the Paediatric Ophthalmology and Strabismus Section Editor for the British Journal of Ophthalmology, the Current Eye Research, and the BMJ Open Ophthalmology. He has presented widely, is invited as keynote speakers at both national and global levels, and is passionate about teaching.
Rania Maklad is the CEO and Co-Founder of OCUWELL, a health technology company focused on improving eye care through innovation and accessibility. With a background in healthcare management and digital innovation, Rania has played a key role in shaping OCUWELL's goal of making vision screening and eye health monitoring more proactive and personalized.
Under her leadership, OCUWELL has grown from a simple idea into a developing startup, known for its AI-powered diagnostics and eye health solutions. Rania’s vision has helped position OCUWELL as an emerging player in the region’s health-tech sector, collaborating with clinics, research institutions, and corporate wellness programs.
Rania is also passionate about promoting inclusive innovation and supporting women’s involvement in technology, encouraging others in the Middle East to explore how digital solutions can enhance quality of life.
Consultant Cornea and Refractive surgery Clinical and translational Scientist, Narayana Nethralaya, Bangalore, INDIA GROW laboratories Faculty, Dept. of Ophthalmology, Univ. Maastricht.
Prof. Dr. Rohit Shetty is the Vice Chairman of Narayana Nethralaya Eye Institute. He is a Professor at Sri Devaraj Urs Medical College, India and an Adjunct Associate Professor at MS Ramaiah Medical College, Bangalore and is an Affiliate Associate Professor and PhD guide at the Maastricht University in the Netherlands. Prof. Dr. Rohit Shetty has over 200 Publication in peer reviewed indexed Journals. He is a Corneal Refractive Surgeon at Narayana Nethralaya Eye Institute, Bangalore, India. His other areas of work include Neuro-ophthalmology electrophysiology.
Prof. Dr. Rohit Shetty defended his PhD from Maastricht University, Netherlandson Understanding the Clinical, Immunological and Genetic Molecular Mechanism of Keratoconus. He has a special interest in the management of Keratoconus, tear film abnormalities and biomarkers. He has introduced cutting edge technology at Narayana Nethralaya and spearheads treatment for challenging eye disorders.
In the 2015 annual conference of the All India Ophthalmological Society, Dr. Rohit Shetty won the prestigious Col. Rangachari award for the overall best paper of the conference for his work on “Is Inflammation Driving Keratoconus? – A Holistic Study Of Molecular Pathways”.
The American Academy of Ophthalmology recently conferred an achievement award to Dr. Rohit Shetty for the distinguished services he has rendered over the years to the programs of the society.
Dr. Rolando Toyos is a globally renowned ophthalmologist and one of the world’s leading dry eye specialists, celebrated for his groundbreaking contributions to the treatment of dry eye disease (DED). As the founder and medical director of Toyos Clinic, with locations in Tennessee, Mississippi, and New York City, Dr. Toyos has transformed the landscape of ocular health through his innovative approaches and dedication to patient care.
A pioneer in the field, Dr. Toyos is the inventor of Intense Pulsed Light (IPL) therapy for dry eye, a revolutionary treatment that targets meibomian gland dysfunction (MGD), a primary cause of evaporative dry eye. His FDA-approved Toyos Protocol, developed over 25 years of research, is the only peer-reviewed IPL protocol for DED and is utilized by top eye care centers worldwide, including prestigious institutions like the Mayo Clinic, Johns Hopkins, and Stanford. Dr. Toyos has trained hundreds of surgeons globally, establishing himself as a trailblazer in advancing dry eye treatment standards.
In addition to IPL, Dr. Toyos has developed cutting-edge technologies like The Q, a portable light therapy device that empowers patients to manage dry eye symptoms at home and Platelet Rich Plasma PRP eyedrops and microneedling of the tear producing glands. His holistic approach to DED emphasizes the critical role of diet and lifestyle, detailed in his acclaimed book, *Toyos Dry Eye Diet: What to Eat to Heal Your Dry Eyes*, which provides science-based guidance for lasting relief. His earlier works, including *Dry Eye Disease Treatment in the Year 2020*, are celebrated by patients and professionals alike for their insights into innovative treatments.
Board-certified in ophthalmology, Dr. Toyos is also a highly experienced surgeon, having performed over 35,000 cataract surgeries, 25,000 LASIK procedures, and 20,000 glaucoma laser treatments. His expertise extends to serving at one time as the official eye doctor for professional sports teams, including the Memphis Grizzlies and Memphis Redbirds, and as the former president of the Sports Ophthalmology Society of America.
Recognized as a Castle Connolly Top Doctor and Newsweek America’s Best Doctors, Dr. Toyos has received numerous accolades, including the Humanitarian Award from the Jazz Foundation of America for his work with Hurricane Katrina victims and the Leadership Award from the National Hispanic Professional Organization. His commitment to community service includes mission trips to Nicaragua, Honduras, Colombia, and Haiti, as well as volunteering with Eye Care America to provide free care to underserved populations.
Dr. Toyos earned his Bachelor’s and Master’s degrees from the University of California, Berkeley, and Stanford University, respectively, and his medical degree from the University of Illinois College of Medicine, where he graduated with James Scholar Academic Honors and was Class President. He completed his ophthalmology residency at Northwestern University and Chicago Children’s Hospital. Through his innovative treatments, extensive research, and compassionate care, Dr. Rolando Toyos continues to redefine the standard of care for dry eye disease, offering hope and relief to patients worldwide.
Dr. Saleh Saif Al Messabi FRCS is one of the most esteemed Ophthalmologists in the region. For his quality of work, he was presented the Best Surgical Performance Award by Health Authority of Abu Dhabi. He is also a recipient of the prestigious Sheikh Rashed Al Maktoum award for Scientific outstanding. Dr. Al Messabi has been known to be a pioneer when it comes to new developments in his field. He is one of the first 2 surgeons to introduce Femto-Cataract surgery to the Middle East in early 2012 and new types of multifocal intraocular lenses. A leader of innovation and one of the first few surgeons in the Middle East to start and to teach the most advanced forms of Corneal transplant like DSAEK and DALK in 2007. Dr. Al Messabi finished his 5 years Ophthalmology Residency training from McGILL University, Canada. He then spent one year further to finish his Cornea and Refractive Surgery clinical fellowship at University of Montreal in 2007, after which he joined Sheikh Khalifa Medical City as Ophthalmology Consultant. During his tenure he established the Corneal Transplant program for SEHA in the same year, 2 years later he founded the Residency program and served until august 2012 as Residency Program Director and Head of Ophthalmology Department. After that, he joined Samaya Eye Hospital in Abu Dhabi as medical director and partner. Dr. Al Messabi is the President of the Emirates Society of Ophthalmology and a very active member in Education and Research. He teaches Medical students in UAE University and has always given lectures in all the major, international conferences like AAO, ASCRS, ESCRS, WOC at different cities around the world.
Dr. Salman Waqar is an experienced consultant ophthalmologist specialising in the treatment of adult glaucoma at Moorfields Eye Hospital Dubai in Dubai Healthcare City. He graduated from Pakistan and has over 15 years’ experience of work in the United Kingdom. He holds a Certificate of Completion of Training from the UK, and is a Fellow of the Royal College of Ophthalmologists. He has worked in various prestigious eye units including the West of England Eye Unit (Exeter), where he completed his sub-specialty training in glaucoma. In his career, he has been appointed as a consultant across a wide range of leading medical institutions such as the Royal Eye Infirmary (Plymouth), Nuffield Health, Medical Eye Clinic and Newmedica. In addition to his clinical work, he has also performed with distinction as director of clinical governance and for the glaucoma service.
Dr. Waqar’s research interests include optimizing patient outcomes with minimally invasive surgery, using virtual reality simulation to investigate surgeon performance and the development of innovative surgical instruments to improve patient safety. He has published extensively in peer-reviewed journals, such as the British Journal of Ophthalmology and the Journal of Cataract and refractive Surgery, and presents regularly at national and international meetings.
Accomplished Ophthalmologist with 20+ years of experience in advanced eye care, complex surgical procedures, and clinical research. Recognized leader in corneal and refractive surgery, with over 50 publications in peer-reviewed journals and presentations at 50+ international conferences. Skilled in managing large ophthalmology departments, mentoring medical professionals, and delivering innovative treatments with proven patient outcomes. Fluent in English, Urdu, Bengali, and Arabic, with strong interpersonal skills that foster trust and collaboration across diverse cultures. Key Expertise • Refractive & Corneal Surgery (LASIK, SMILE, Keratoplasty) • Cataract & Vitreo-retinal Surgery • Ophthalmology Department Leadership • Clinical Research & Publications • Advanced Ophthalmic Technology (Femto, Excimer, MEL 80) • Patient-centered Eye Care & Education Career Highlights Al Zahra Private Hospital, Sharjah & Dubai Consultant & Head of Ophthalmology (2003 – Present) • Performed 50,000+ eye surgeries including refractive, cataract, and corneal transplants. • Among the first in the UAE to complete Femto-assisted SMILE procedures (800 cases, 99% success rate). • Regularly perform advanced corneal surgeries (DALK, DSAEK, DMEK) and pioneering stem cell-based ocular surface reconstruction. • Lead continuous improvement initiatives, ensuring compliance with clinical standards and introducing innovative surgical practices. Centre for Eye Research, University of Melbourne, Australia Senior Fellow (2001 – 2003) • Conducted multi-center research on corneal diseases and surgical innovations. • Performed 6,000+ Excimer laser surgeries, 10,000+ cataract procedures, and advanced vitreoretinal surgeries. • Specialized in big bubble lamellar keratoplasty with successful corneal graft outcomes for keratoconus patients. Sultan Qaboos University Hospital, Oman Lecturer & Head of Ophthalmology (1995 – 2001) • Directed clinical services, education, and departmental policy development. • Performed a wide range of surgeries: vitreo-retinal, keratoplasty, amnion transplants, and advanced cataract techniques. • Trained and mentored medical students and junior doctors, building future ophthalmology leaders. Education & Credentials • MD, All India Institute of Medical Sciences – New Delhi, India • MBBS (Ophthalmology specialization), Jawaharlal Institute of Post Graduate Medical Education & Research – New Delhi, India • Fellowship (FRCS), Royal College of Surgeons, Edinburgh, UK • Fellowship (FRCOphth.), Royal College of Ophthalmology, London, UK • Fellowship, Corneal & Refractive Surgery, Royal Victorian Eye and Ear Hospital, University of Melbourne, Australia • Vitreo-retinal Surgery Training, Moorfield Hospital, London, UK Certifications • Lasik Specialist Certification, Ministry of Health, Government of Dubai, UAE • Certificate, Mel 80 Excimer Laser Training (Carl Zeiss), The London Vision Clinic, London, UK • Fellowship Certification, Excimer Laser Surgery (LASIK, LASEK & PRK), Melbourne Excimer Laser Group, University of Melbourne, Australia • BLS and ACLS Certified • Diplomate of National Board of Examinations, 1993 • IELTS, 2000 Awards • Bodhraj Sabrewal Gold Medal – Best Postgraduate Student in Ophthalmology, 1992 • First Prize – Ophthalmic Quiz, AIIMS, 1993 • First Prize – ORA Quiz, AIIMS, 1992 • Best Ophthalmic Group Award, AIIMS, 1991 • National Scholarship for Distinction in Secondary School Examination, 1979
Dr. Sara AlShaker is a double board certified ophthalmologist (American and Canadian). She is an Assistant Professor and Cornea Consultant at King Saud University (KSU) in Riyadh, Saudi Arabia. She trained at the University of Toronto, where she completed both her residency and a fellowship in Cornea, External Diseases of the Eye, and Refractive Surgery. Dr. AlShaker demonstrates profound leadership as the cornea fellowship director and the KSU Eye Bank Medical Director. She is a recognized national and international speaker, teacher, researcher and is a published author of ophthalmic book chapters. Her dedication to teaching was formally recognized with the Best Speaker Award at the 2024 KSU Basic Science Course, an honor bestowed by the ophthalmology residents. She is recognized for her exceptional surgical expertise, particularly in Descemet Membrane Endothelial Keratoplasty (DMEK) and complex anterior segment surgery, where her refined techniques lead to superior patient outcomes and rapid visual recovery.
Dr. Shady Awwad is a professor of Ophthalmology and the head of the cornea & refractive surgery division at the American University of Beirut Medical Center. He received his medical degree and completed his residency training at the American University of Beirut. He subsequently completed a fellowship in cornea & refractive surgery and then ocular pathology at the University of Texas Southwestern Medical Center in Dallas. Shady’s research and clinical interests are focused on analytical corneal imaging including developing machine learning models, ocular and corneal wavefront analysis, keratoconus diagnosis and treatment, refractive surgery, and intraocular lens calculations after refractive surgery, for which he has two formulas on the ASCRS IOL calculator website. He created a patented technique to analyze optical coherence tomography images of corneal haze and demarcation lines using artificial intelligence and another software to analyze slit lamp photos, among others, and accurately compute corneal lesions coordinates, surface area, and density, ideal for custom ablation area phototherapeutic keratectomy. He has several online ophthalmology software and tools. He has been awarded , the Alpha Omega Alpha honor society award, the American Academy of Ophthalmology achievement award, and the George Waring Medal for editorial excellence from the Journal of Refractive Surgery.
Dr. Shatha Hussein Alfreihi is a leading pediatric ophthalmologist in Saudi Arabia, currently serving as Head of the Pediatric Ophthalmology Division and Deputy Chairman of the Department of Pediatric Surgery at King Abdullah Specialist Children's Hospital in Riyadh.
She completed advanced fellowship training in pediatric ophthalmology and strabismus at George Washington University and the University of California, Los Angeles (UCLA), building on her board certification in ophthalmology. Throughout her career, Dr. Alfreihi has contributed extensively to the field through peer-reviewed publications, national and international presentations, and active involvement in academic programs such as journal clubs, teaching activities, and research committees.
An active member of several professional societies, Dr. Alfreihi has been recognized with multiple awards honoring her clinical excellence, leadership, and service. She is widely regarded for her dedication to advancing pediatric eye care and for her ongoing commitment to improving visual health outcomes for children across Saudi Arabia and beyond.
Sheikha Dr Al Qassimi graduated from the Faculty of Medicine and Health Sciences, United Arab Emirates University (MBBS).
She did her internship in Al Ain hospitals, then left for Cairo, Egypt to pursue her master's degree in Kasr El-Aini.Sheikha Dr. Al Qassimi joined the residency program in the Ophthalmology Department at Bonn University Hospital where Prof Dr. Frank Holz is the Chief of the Ophthalmology Department. Her experiences included general ophthalmology and all the subspecialties including procedures and surgeries. After getting the German Board (FACHARZT), she completed 2 years Fellowship in the same department in Medical Retina
Then joined Moorfield's Eye Hospital under Prof Dr. Sue Lightman's supervision for an 18-month fellowship in Uveitis and Medical Retina as a full registered Doctor at the General Medical Council.
During that period, she was engaged in the clinical practice and research facility, as she conducted several multi-center research clinical trials.
She has a wealth of experience in diagnosing, investigating, and managing conditions such as Diabetic Retinopathy, Vascular retinopathy, retinal degenerations and dystrophies, macular diseases, and inflammatory eye diseases.
Currently, Sheikha Al Qassimi is Devision Chief of Ophthalmology department and consultant in medical retina and uveitis at Shaikh Khalifa Medical City, Abu Dhabi.
Engaged in several retinal guidelines and research
She is the President of the Emirates Medical Association and the Emirates Society of Ophthalmology.
She is the Division Chief of the Ophthalmology Department at Sheikh Khalifa Medical City.
Dr Al Qassimi is a member of the American Academy of Ophthalmology, The American Society of Retina Specialists, Euretina and International Uveitis Study Group.
Dr. Sihem Lazreg, ophthalmologist specializing in medical cornea and ocular surface Former assistant professor at Mustapha University Hospital, she now practices privately in a clinic entirely dedicated to her specialty. Consultant in the field of dry eye and ocular surface for numerous international advisory boards Member of all societies for cornea, refractive surgery, and contact lenses. Member of the board of directors of the French ophthalmology society SFO since 2019. Member of the board of directors of JRO (France), EPOMEC, and the International Keratoconus Society. Member of the board of directors of OSN (ocular surgery news), a French ophthalmology journal, and ophthalmology Author of dozens of articles and book chapters on ocular surface diseases, including three SFO reports; Recipient of numerous awards and distinctions from regional and European societies, Member and author of DEWS 2 and TFOS lifestyle workshops EMEA ambassador for TFOS DEWS2 Member of the European Dry Eye Society President of the Algerian Glaucoma Society Founder and president of the Dry Eye and Ocular Surface Society (DEOSS)
Dr. Mustafa graduated in Medicine with a Commendation from the UK and undertook his residency in General Ophthalmology in the UK. He has completed training in UK and part of it has been in prestigious Eye Hospitals such as Royal Victoria Eye and Ear Hospital (Dublin) and Moorfields Eye Hospital, London. He is a certified Consultant in the UK having worked there previously. He has trained thoroughly in General Ophthalmology and undertook his fellowship training in Adult and Paediatric (Childhood) Glaucoma at Manchester University Hospital and Moorfields Eye Hospital in London, UK, working under eminent clinicians within the Glaucoma fraternity. He has worked in the UAE since 9 years as a formative Consultant Ophthalmologist at Moorfields UAE and now is the Director of Ophthalmology Services at American Hospital Dubai.
Stefano Barabino is Head of the Ocular Surface & Dry Eye Center at the Sacco Hospital, Milan University, Italy. He received his medical doctor degree from Genoa University, completed his residency in Ophthalmology, and received his Ph.D. degree in Immunology.
Dr. Barabino completed a two-year fellowship at Harvard University, in Boston, USA. As specialist in dry eye, ocular surface diseases, and contactology, he has published more than 200 scientific articles in Italian and International scientific journals. He is an active member of several European and International professional societies, President of the Italian Society of Ocular Surface, board member of Ocular Immunology & Inflammation, Eye & Contact Lens, The Ocular Surface, BMC Ophthalmology, Current Eye Research, TVST.
Dr. Barabino has been an active member of the Tear Film & Ocular Surface Society (TFOS) since its inception in 2000 and founding member of the European Dry Eye Society (EUDES).
Dr. Sultan Aldrees, MD, MSc, FRCSC, is a Consultant Ophthalmologist and Cataract, Glaucoma, and Advanced Anterior Segment Surgeon at King Saud University in Riyadh, Saudi Arabia. He graduated with Honours from the College of Medicine at King Saud University, earning multiple academic distinctions. He subsequently completed a Master of Science degree at McGill University, where he was awarded the Henry C. Witelson Ocular Pathology Fellowship Award.
Dr. Aldrees completed his ophthalmology residency training at the University of Toronto, receiving the Kensington Eye Institute Surgical Proficiency Award, and obtained his certification from the Royal College of Physicians and Surgeons of Canada. He then pursued a two-year fellowship in Cataract, Glaucoma, and Advanced Anterior Segment Surgery at the University of Toronto under the mentorship of Dr. Ike Ahmed.
His clinical practice focuses on cataract surgery, glaucoma management, and advanced anterior segment reconstruction, including IOL exchanges and repositioning, secondary IOL implantation, and iris reconstruction. He currently serves as Residency Program Director and Cataract & Glaucoma Fellowship Director in the Department of Ophthalmology at King Saud University, where he is actively involved in resident and fellow training.
Dr. Sumayya Almarzooqi is a highly accomplished Neuro-Ophthalmology Consultant with extensive clinical and academic experience in the UAE and internationally. She earned her MBBS from the University of Jordan and completed her Ophthalmology Residency at Mafraq Hospital in Abu Dhabi, followed by a Neuro-Ophthalmology Fellowship at Houston Methodist Hospital, Texas, USA.
She has held key clinical roles at Sheikh Shakhbout Medical City, Burjeel Medical City, and Dr. Sulaiman Al Habib Hospital, where she continues to provide subspecialty care in optic neuropathies, papilledema, idiopathic intracranial hypertension, visual field disorders, and complex cranial nerve pathologies.
Deeply committed to education, Dr. Almarzooqi serves as Adjunct Assistant Professor at UAE University’s Faculty of Medicine and Health Sciences and as a faculty member in the Abu Dhabi Ophthalmology Residency Program. She previously directed the Mafraq Ophthalmology Residency Program and is currently pursuing a Master of Leadership in Health Professions Education at the University of Sharjah.
She is also an active member of several professional societies, including the North American Neuro-Ophthalmology Society (NANOS), the American Academy of Ophthalmology, and the Emirates Society of Ophthalmology, where she has held leadership roles in its scientific committees.
Dr. Tahra AlMahmoud, Department of Surgery, College of Medicine and Health Sciences, United Arab Emirates University. Completed Ophthalmology residency at McGill University and is a Fellow of Royal College of Surgeon of Canada. Her research focuses on exploring reasons for eye related morbidity and its prevention.
Tamer Mahmoud, MD, PhD is a professor of Ophthalmology at Oakland University William Beaumont School of Medicine and the director of the vitreoretinal fellowship at Associated Retinal Consultants. He moved from North Carolina in 2017 where he was the program director of the vitreoretinal surgery fellowship at the Duke University Eye center and a tenured associate professor at Duke. He has developed many surgical techniques over the years with his fellows including the use of subretinal air to displace submacular hemorrhage in 2013 and developed and performed the first human autologous retinal transplantation in 2015. He also introduced chandelier buckles to the United States and in 2017, developed the ILM retracting door technique for macular holes. The nano subretinal gateway device was developed in 2019 to access the subretinal space without PPV to displace subretinal hemorrhage, but also for injection of gene therapy, drugs, removal of PFO and tumor biopsy. In 2022, the concept of using the epiretinal membrane to close large macular holes was introduced in cases of combined large holes with membranes. In 2023, he developed and performed the first combined amniotic and autologous retinal transplant for large refractory myopic macular holes with some atrophy. For the last few years, Dr. Mahmoud has focused on running global studies to treat macular holes by working with surgeons around the world to develop guidelines to treat challenging holes using many techniques that have been developed over the years.
Dr. Mahmoud graduated Valedictorian from Ainshams University, finished his internship, residency and vitreoretinal fellowship at the Duke University Eye Center. He is a member of the American Academy of Ophthalmology (AAO), the Association of Research in Vision and Ophthalmology (ARVO), the American Society of Retina Specialists, the Club Jules Gonin, the Macula Society, the Retina Society, The Vitbuckle society, and the United States Masters Swimming Association. He is a reviewer for many Ophthalmology journals and a principal investigator on many clinical trials sponsored by the industry and the National Eye Institute. He has been invited as a guest speaker all over the world. Dr. Mahmoud is certified by the American Board of Ophthalmology and is licensed in the states of California, Michigan, and North Carolina.
Dr. Mahmoud received the Edward K. Isbey, Jr., M.D. Resident Award for "Excellence in Clinical Care, Ethics, and Research" from the Duke Eye Center, the Retina Research Foundation/"Joseph M. and Eula C. Lawrence" award from ARVO, the "Senior Honor Award" and the “Presidential Honor Award” from the American Society of Retina Specialists, the “Achievement Award” from the AAO, the prestigious Robert A. Machemer research award from the Duke Eye Center, the "Distinguished Teacher of the Year Award" from the Kresge Eye Institute and the “Golden Globe Award” for residents’ education from the Duke Eye Center.
Dr. Mahmoud has been on the list of Best Doctors in America since 2009 and Castle Connolly Top Doctors in Ophthalmology. He was the director of the Vitreoretinal Surgery Fellowship at the Kresge Eye Institute in Michigan before moving back to Duke in 2011 to join the retina faculty. Wayne State University-Kresge Eye Institute established the "Tamer H. Mahmoud, MD endowed fellowship research award" in 2012. This award is bestowed yearly to the fellow presenting the best paper.
Dr. Mahmoud is a founder of the Duke Surgical Rounds Courses launched at national and international conferences in 2013, and co-founder of the Duke fellows advanced vitreous surgery course (fAVS). He served on the national Therapeutic Safety Committee (TSC) for monitoring of drugs and devices and founded the North Carolina Retina Club (NCRC) in 2012 to allow interaction and collaboration between retina specialists in the state of North Carolina.
A natural visionary Leader with unique Coaching and Transformational abilities with a phenomenal track record of challenging businesses turnaround.
Having been in Pharma for more than 35 years, heading a mix of senior Commercial and General Management Leading roles over the last 26 years, the last 15 years, in particular, were strong career highlights.
Between 2009 and 2018, filled the senior Executive Roles as a Regional President leading Pfizer's various business segments, Consumer Health, Nutrition, and Pharmaceuticals, and leading businesses ranging from $400M - $B 1.3 in regions like Europe, the Middle East, and Africa.
Currently the CEO of Jamjoom Pharma, one of the leading regional players in the Middle East.
Dr. Tariq Al-Rawashdeh is a Consultant Ophthalmologist and Vitreoretinal Surgeon for last 14 years after a 12 years of training Internationally, included his fellowships in Hamburg university hospital and Charite University hospital Berlin.
Tariq strong points in eye medical and surgical care Vitreoretinal surgery included diabetic retinopathy, complex retinal detachment with the latest technology, all types of implants, cataract surgery and refractive surgery.
Dr. Tariq Al-Rawashdeh is holding multiple International board certificates during his training included European Board of Ophthalmology FEBO Paris, German Board of Ophthalmology Facharzt Berlin, Jordanian Board of Ophthalmology Amman and International Council of Ophthalmology ICO London.
Dr. Tariq Alzahem is a consultant ophthalmologist and vitreoretinal surgeon at King Saud University, Riyadh. He graduated from the College of Medicine at King Saud University with First Class Honours, receiving multiple awards including the Ideal Student Prize and the King Saud University Golden Medal. He completed his ophthalmology residency at King Saud University Medical City, where he was named Resident of the Year for three consecutive years, and later obtained both the Saudi and King Saud University Boards of Ophthalmology. Dr. Alzahem subsequently completed a fellowship in Vitreoretinal Diseases and Surgery at King Khaled Eye Specialist Hospital (KKESH). His clinical work focuses on cataracts, medical retina, and vitreoretinal surgery, and he is actively involved in resident and fellow training.
Founder, CataractCoach.com The world’s largest cataract surgery teaching website with 1850+ videos, 16 million views, 52000 subscribers, and a new video every day. Academic Appointment:
Dr. Waleed Ghobashy; Assistant Professor and Consultant of Ophthalmology, Faculty of Medicine, Suez Canal University, Egypt. After serving for a year in Moorfields Eye Hospital Center, Abu Dhabi as consultant ophthalmology. Dr. Waleed started a new role in October 2020 as the Medical Director & Head of Glaucoma & Cataract Unit, Magrabi Eye Center, Al Ain, UAE Dr. Waleed started his career in the ophthalmology field in 1996 as a resident in Suez Canal University Hospital, Egypt. He received his master degree in ophthalmology in 2000 in field of cataract surgery. He received advanced ophthalmology training from 2000 to 2005, concluded by passing MD exams , and getting his PhD thesis in “Ocular changes after myopic LASIK” from Faculty of Medicine, Suez Canal University, Egypt. His supervisor was the Refractive Pioneer Prof. Dr. Karem Kolkailah. Dr. Ghobashy then moved to Knoxville, TN, USA to act as the clinical fellow of Dr. Steven Sterling MD; the distinguished phaco refractive surgeon of East Tennessee 2005 to 2007. Dr. Waleed Ghobashy then returned home to act as clinical lecturer and consultant of ophthalmology in faculty of Medicine, Suez Canal University. From 2007 till present, Dr. Ghobashy did extensive research and clinical work in refractive surgeries, cataract, glaucoma, medical retina and Electrophysiological diagnosis of ocular diseases, with over 30 published research papers in many regional and international scientific journals, gained the title of Assistant Professor of ophthalmology in 2014. Dr. Ghobashy is a member of many ophthalmology associations, and a speaker in the annual meetings of the most prestigious ophthalmological societies including American Academy of Ophthalmology (AAO), European Society of Cataract and Refractive Surgeons (ESCRS), American Society of Cataract and Refractive Surgeons (ASCRS), Egyptian Society of Ophthalmology (ESO), Emirates Society of Ophthalmology
Executive Vice President of Research & Development and Chief Medical Officer
Yehia Hashad is an ophthalmologist and retinal specialist with more than 25 years of leadership experience in various ophthalmology global research and development roles, including his current role as the Executive Vice President of Research & Development and Chief Medical Officer at Bausch + Lomb.
Most recently, Dr. Hashad was with Allergan/AbbVie where he served as Senior Vice President and Head of R&D for Allergan Aesthetics from 2020 through August 2021. There, he oversaw the development of more than 40 programs that spanned pharmaceutical products, fillers, reconstructive surgery, devices and consumer skin care. From 2010 until Allergan's acquisition by AbbVie in 2020, Dr. Hashad held a number of executive R&D positions at Allergan, including Senior Vice President and Head of Global Clinical Development; Vice President and Global Head of Clinical Development, Ophthalmology, Dermatology and Medical Aesthetics; and Vice President and Global Head of the Ophthalmology and Retina therapeutic areas.
Prior to Allergan, Dr. Hashad spent five years with Novartis Pharma AG, where he served as a Global Medical Director for age-related macular degeneration-related treatments Visudyne® and Lucentis® and as a Medical Director, Ophthalmology, for the European region. From 1996 to 2005, he held positions of increasing responsibility at T3A Pharma Group. Dr. Hashad obtained his Master of Science in Medical and Surgical Ophthalmology from Cairo University and a business degree from INSEAD in France. He previously served on the boards of The Glaucoma Research Foundation and the National Alliance of Eye and Vision Research and is currently a board adviser for the University of California Irvine Research Center.
Dedicated ophthalmologist with extensive experience in anterior segment surgery. Trained in cataract and refractive surgery, with hands-on experience in various clinical settings. Passionate about delivering high-quality eye care and staying up to date with the latest surgical techniques.
Since 2018, he has been the Deputy Director for Innovation at the Federal State Budgetary Scientific Institution "Research Institute of Eye Diseases". He is the director of the Federal State Budgetary Institution "Scientific Research Institute of Eye Diseases" from 2020 to the present. In 2022, Dr. Yusef was awarded the academic title of professor. In 2022, he was awarded the state award of the Russian Federation - the Medal of Friendship. Yusef Naim Yusef carries out close scientific cooperation with many leading ophthalmologists and the clinics of the world, he is a certified specialist of the world's leading manufacturers of ophthalmic equipment: Alcon, Baush&Lomb, Schwind, Topcon, etc. Yusef Naim Yusef is one of the most respected ophthalmologists in Russia. Dr. Youssef plays a big role in improving Russian-Arab relations. Thousands of patients have been consulted and received surgical care from the Arab world. The doctor has repeatedly performed microsurgical eye operations in the Arab world. Special attention is paid to Russian-Syrian relations. Dr. Yusef has repeatedly performed on central Russian television channels, several cycles of broadcasts on Al Jazeera and Russia Aliom channels were dedicated to him, and he owns many publications in the central press.
Dr. Yousif A. Al Zafiri, MD, FRCS(C)
Consultant Ophthalmologist & Founder, YAS Clinic, Kuwait
Dr. Yousif Al Zafiri is a Canadian Board–certified ophthalmologist and glaucoma specialist with more than two decades of clinical and surgical experience. He is the Founder and Lead Consultant at YAS Clinic, Kuwait, a private practice he established to deliver advanced, patient-centered eye care.
A native of Kuwait City, Dr. Al Zafiri obtained his Medical Degree (MB, BCh, BAO, NUI) from University College Cork, Ireland in 1994. He pursued residency training in ophthalmology at Ibn Sina Hospital, Kuwait, and subsequently advanced his training in Canada, completing a Glaucoma Fellowship at the University of Montreal (2003) and earning his FRCS(C) in Ophthalmology from McGill University.
Before founding YAS Clinic, Dr. Al Zafiri served as Medical Director and Chief Medical Officer at Dar Al Shifa Hospital (2005–2021), where he built and led one of the largest private ophthalmology services in Kuwait. His previous appointments include Consultant Ophthalmologist and Deputy Head of Department at Saad Hospital in Saudi Arabia and Senior Registrar at Al Bahar Eye Center in Kuwait.
He is recognized as a pioneer in the region, being the first surgeon in Kuwait to perform ReLEx SMILE refractive surgery (2001) and the first to introduce Express valve glaucoma surgery (2009). His clinical expertise spans glaucoma, anterior segment, cataract, refractive, and laser procedures.
Dr. Al Zafiri is a member of leading international professional societies, including the American Academy of Ophthalmology (AAO), the Canadian Ophthalmology Society, the Royal College of Physicians and Surgeons (Canada), the Irish & Kuwait Medical Association, the European Society of Cataract & Refractive Surgeons (ESCRS), and the Association for Research in Vision & Ophthalmology (ARVO).
He is a frequent speaker at international ophthalmology conferences and remains committed to advancing patient care, surgical innovation, and professional education in the field of ophthalmology
Dr. Oshima graduated from Osaka University Medical School and completed his residency and fellowship in vitreoretinal surgery at Osaka University Hospital under the mentorship of the late Dr. Yasuo Tano. After serving for over a decade as an Associate Professor at Osaka University, he is now the Founder and Director of the Seiyukai Medical Corporation, which operates three specialized centers for vitreoretinal and cataract surgery in Osaka, Japan. Collectively, these centers perform more than 5,000 surgical cases annually.
Dr. Oshima is internationally recognized for his pioneering work in developing the 27-gauge vitrectomy system, which has significantly advanced minimally invasive retinal surgery. He is a prolific author of scientific papers published in leading journals such as Ophthalmology, American Journal of Ophthalmology (AJO), and British Journal of Ophthalmology (BJO).
A sought-after speaker, Dr. Oshima has delivered numerous invited lectures across Asia, Europe, and the United States, and has performed live surgical demonstrations at major international meetings including the Frankfurt Retina Meeting, Floretina, and the Cairo Retina Meeting.
He serves on the Editorial Board of Retina Today and holds memberships in several prestigious ophthalmologic societies, including the American Academy of Ophthalmology (AAO), the American Society of Cataract and Refractive Surgery (ASCRS), and currently serves as the Liaison for International Affairs for the American Society of Retina Specialists (ASRS).
In recognition of his contributions to the field, Dr. Oshima has received numerous honors, including:
Ziad Khoueir, MD, MSEd, FEBOS-GL
Dr. Khoueir completed his residency at the Saint-Joseph University in Beirut. He then pursued his glaucoma training by obtaining postdoctoral fellowships from the Glaucoma Institute in Paris (UPMC Sorbonne University, Paris, France) and subsequently from the Massachusetts Eye and Ear Infirmary Hospital in Boston (Harvard Medical School, Boston, USA).
Dr. Khoueir received the young ophthalmologist scholarship award during the 8th International Congress on Glaucoma Surgery in 2016.
Dr. Khoueir currently holds the position of associate director of the Glaucoma division at the Beirut Eye and ENT Specialist Hospital. He is also a visiting Consultant ophthalmologist specialising in adult glaucoma and cataract surgery at Moorfields Eye Hospital Dubai in Dubai Healthcare City.
He’s a research collaborator at the Mayo Clinic Ophthalmology department. He’s a clinical instructor and lecturer at the Saint-Joseph University medical school in Beirut. He is the co-chair of the associate advisory board of the World Glaucoma Association and a member of the executive committee of the International Society of Glaucoma Surgery. He is also a member of the board of the Middle East and Africa Glaucoma Society and the Lebanese Ophthalmological Society.
Dr Khoueir chairs the Glaucoma Committee of the European Society of Cataract and Refractive Surgery.
His research focuses on innovative techniques in managing and diagnosing glaucoma, such as minimally invasive glaucoma surgery (MIGS), glaucoma lasers and the use of Optical Coherence Tomography imaging in glaucoma. He has published more than 40 research papers and chapters on those topics in leading ophthalmology journals. He has been invited to lecture and present his work in regional and international meetings in more than 20 countries over the last few years.
José Benítez-del-Castillo is the Director of the Ocular Surface and Inflammation Unit at the Hospital Universitario San Carlos de Madrid, and is Full Professor and Chairman of the Faculty of Medicine, Ophthalmology, University of Complutense, Madrid. He is a member of The Spanish Society of Ophthalmology Board of Directors, Vice President of the Spanish Society of Ocular Surface and Cornea, Vice President of the Spanish Society of Ocular Inflammation and Uveitis, Publications Director of the Spanish Society of Cataract and Refractive Surgery, and General Secretary of the Spanish Society of Ophthalmology. For the last 8 years Professor Benítez-del-Castillo has been Editor of the Spanish Journal of Ophthalmology (Archivos de la Sociedad Española de Oftalmología), as well as part of the Editorial Board of the Journal of Optometry and The Turkish and Polish Journal of Ophthalmology since 2009, and is Associate Editor of Ophthalmic Research. He has published more than 250 papers in international peer-reviewed journals and is a reviewer for nine scientific journals, including Ophthalmology and The Lancet, and has carried out over 450 oral or poster presentations at international congresses including ARVO, Tear Film & Ocular Surface Society (TFOS), EVER and the American Academy of Ophthalmology. Dr. Benítez-del-Castillo was part of the TFOS Meibomian Gland Dysfunction Workshop and the TFOS Dry Eye Workshop II (Management and Treatment Subcommittee)
With over two decades of experience in the pharmaceutical industry, Lasse is a seasoned executive known for driving strategic growth and operational excellence across international markets. He is currently serving as Vice President for the Central Region, EMEA at Santen, a Japan-based, global healthcare company focused exclusively on eye health. Lasse oversees operations spanning the Nordics, Baltics, DACH, UK & Ireland, and the Middle East—managing a regional team of approximately 200 international professionals. In his role, he overlooks around 600 marketing authorizations for +30 prescription products across the EMEA region that help people protect and preserve their sight. He supports HR and finance operations for 17 representative offices and 3 filial entities across Central and Eastern Europe. Lasse’s industry knowledge and cross-functional leadership have consistently contributed to the company's growth and regional integration strategies. As a member of the Santen European Leadership Team, he plays a pivotal role in shaping Santen's broader European business agenda, strengthening its position as a trusted leader in eye health. Lasse's contribution has been crucial in ensuring seamless collaboration with key internal and external stakeholders. Throughout his career, Lasse has demonstrated ability to lead diverse teams, navigate complex market environments, and deliver sustained commercial success in highly competitive landscapes.
Daniele Tognetto is Full Professor of Ophthalmology and Director of the Eye Clinic at the University of Trieste, where he has performed over 20,000 surgical procedures on cataract, retina, cornea, and glaucoma; graduated in Medicine and Surgery with honors in 1987 and specialized in Ophthalmology with honors in 1991, he has progressed from researcher to full professor, leading the residency program and training new generations of surgeons; his research focuses on vitreoretinal and cataract surgery, intraocular lenses, biomaterials, and artificial intelligence applications in ophthalmology, resulting in more than 160 peer-reviewed publications and several scientific book chapters; he has been an invited speaker at numerous international congresses and has performed over 40 live surgeries at major scientific events; past President of the Italian Society of Cataract and Refractive Surgery (AICCER) and formerly President of the Italian Society of Vitreoretinal Surgeons (GIVRE) and the Triveneta Ophthalmology Society (SOT), he is also an active member of leading international ophthalmic societies; throughout his career he has received prestigious awards, including two Best Paper Awards from the American Society of Cataract and Refractive Surgery (ASCRS) and several prizes from the Italian Society of Ophthalmology (SOI).
Renowned ophthalmologist and academic leader with over three decades of experience in ocular surface diseases, dry eye, and inflammation. Currently serving as Chair of Ophthalmology at Universidad Complutense de Madrid and Head of the Ocular Surface and Inflammation Unit at Hospital Clínico San Carlos. Internationally recognized for contributions to research, education, and clinical practice in ophthalmology.
Harminder Singh Dua, CBE, CMLJ, DL
MBBS, DO, DO(London), MS, MNAMS, FRCS(Edinburgh), FEBO, FRCOphth, FRCP(Edinburgh, Hon.), FCOptom.(Hon.), FRCOphth.(Hon.), FAICO (India, Hon.), MD, PhD, is Chair and Professor of Ophthalmology at the Queens Medical Centre, University of Nottingham since 1994, Consultant Ophthalmologist, Nottingham University Hospitals NHS Trust, Honorary Professor at Universita della Svizze, Lugano, since 2010 and Honorary Professor at the Research Institute of Ophthalmology, Cairo Egypt.
He was made Commander of the most excellent order of the British Empire by Her Majesty Queen Elizabeth II in her 2019 Birthday Honours list and served a full term as the High Sheriff of Nottinghamshire (2021-22). He was also awarded the NHS Parliamentary Lifetime Achievement award for the Midlands, commissioned as a Deputy Lieutenant (DL) in the Lieutenancy of Nottinghamshire and awarded the high rank of Commander of Merit of the Military and Hospitaller order of Saint Lazarus of Jerusalem (CMLJ). He is a member by invitation of two prestigious institutions namely the Academia Ophthalmologica Internationalis (AOI, an institution of 100 Professors of Ophthalmology) and the American Ophthalmological Society (AOS, the first UK member of this institution of 250 members).
He was the Master of the Oxford Ophthalmological Congress (2019-2020), President of several international organisations namely, Royal College of Ophthalmologists UK (2011-14), of EuCornea (2011-13), of the European association for vision and eye research (EVER, 2008), and of the EVER Foundation (2010-14 and 2016-2020). He was Editor in chief of the BJO (2007-14) and EuCornea Journal (2015-22) and has been recently appointed as Editor-in-chief of the Eye Journal to start from the first of January 2026, and as the International Convenor of the Cornea section of the World Ophthalmology Congress to be held in Prague in July 2026.
Among his over 150 awards and accolades are the Rotary Foundation Global Alumni Service to Humanity Award (2013), The Times Higher Education Award 2014 for 'Research project of the year' and the Melvin Jones Fellow (Award) Lions Clubs International Foundation for humanitarian work. He has been endowed with Honorary Fellowships of the Royal College of Ophthalmologists UK, the Royal College of Physicians of Edinburgh, the College of Optometrists UK, and the Collegium of the All India Ophthalmological Society; the highest accolades conferred by the respective Colleges. One eponymous lecture, "The Dua Lecture" Birmingham, and a seminar room in the Nottingham post-graduate centre, "The Dua Room" are named in his honour.
He has supervised 55 PhD/MPhil students, has over 500 publiations with over 33500 citations and an H-index of 87 (Google scholar July 2025). His discovery of the pre-Descemet's layer (Dua's layer) in 2013, in the human cornea has had considerable impact on lamellar corneal surgery and corneal pathology.
Professor & Head of Ophthalmology Department, Alexandria University, Egypt Elected board member of The Egyptian Society of Ophthalmology (EOS) TFOS (Tear Film and Ocular Surface Society) Global Ambassador President of The Egyptian Society of Keratoconus & Cornea Transplant (ESKC&CT) Vice President of The International Keratoconus Society (IKS) Vice President of The Dry Eye & Ocular Surface Society (DEOSS) Board member of the Egyptian Society of Ocular Implants and Refractive Surgery (ESOIRS), the Egyptian Society of Cataract and Refractive Surgery (EgSCRS) & the Egyptian Refractive Club (ERC) Winner of many honors and awards from the Egyptian and regional Societies of Refractive Surgery. International Global Advisory Board Member of Cataract and Refractive Surgery Today (CRSTE) Author of more than 60 Original Articles and Book Chapters in the Field of Refractive Surgery.
Professor of Ophthalmology at Universidad Complutense de Madrid (Spain) and Chief of Motility Unit and Pediatric Opthalmology at Hospital Universitario Clinico San Carlos of Madrid.
Sign up now to our newsletter